<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39044822</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis.</ArticleTitle><Pagination><StartPage>1422940</StartPage><MedlinePgn>1422940</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1422940</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1422940</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), long COVID (LC) and post-COVID-19 vaccine syndrome show similarities in their pathophysiology and clinical manifestations. These disorders are related to viral or adjuvant persistence, immunological alterations, autoimmune diseases and hormonal imbalances. A developmental model is postulated that involves the interaction between immune hyperactivation, autoimmune hypophysitis or pituitary hypophysitis, and immune depletion. This process might begin with a deficient CD4 T-cell response to viral infections in genetically predisposed individuals (HLA-DRB1), followed by an uncontrolled immune response with CD8 T-cell hyperactivation and elevated antibody production, some of which may be directed against autoantigens, which can trigger autoimmune hypophysitis or direct damage to the pituitary, resulting in decreased production of pituitary hormones, such as ACTH. As the disease progresses, prolonged exposure to viral antigens can lead to exhaustion of the immune system, exacerbating symptoms and pathology. It is suggested that these disorders could be included in the autoimmune/adjuvant-induced inflammatory syndrome (ASIA) because of their similar clinical manifestations and possible relationship to genetic factors, such as polymorphisms in the HLA-DRB1 gene. In addition, it is proposed that treatment with antivirals, corticosteroids/ginseng, antioxidants, and metabolic precursors could improve symptoms by modulating the immune response, pituitary function, inflammation and oxidative stress. Therefore, the purpose of this review is to suggest a possible autoimmune origin against the adenohypophysis and a possible improvement of symptoms after treatment with corticosteroid replacement therapy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Ruiz-Pablos, Paiva and Zabaleta.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruiz-Pablos</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Biological Sciences, Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n M&#xe9;dica Aplicada (CIMA), IdiSNA, Instituto de Investigaci&#xf3;n Sanitaria de Navarra, Clinica Universidad de Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabaleta</LastName><ForeName>Aintzane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n M&#xe9;dica Aplicada (CIMA), IdiSNA, Instituto de Investigaci&#xf3;n Sanitaria de Navarra, Clinica Universidad de Navarra, Pamplona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ASIA syndrome</Keyword><Keyword MajorTopicYN="N">EBV</Keyword><Keyword MajorTopicYN="N">HLA-II</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">hypophysitis</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">post-COVID-19 vaccine syndrome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>24</Day><Hour>4</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39044822</ArticleId><ArticleId IdType="pmc">PMC11263040</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1422940</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vesely DL, Mastrandrea P, Samson C, Argyelan G, Charvit S. Post-herpes encephalitic anterior pituitary insufficiency with hypothermia and hypotension. Am J Med Sci. (2000) 320:273&#x2013;7. doi:&#xa0;10.1097/00000441-200010000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-200010000-00008</ArticleId><ArticleId IdType="pubmed">11061353</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers VK, Hipkin LJ, Hughes RO, Davis JC. Panhypopituitarism after cured tuberculous meningitis. Br Med J. (1968) 1:359. doi:&#xa0;10.1136/bmj.1.5588.359</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.5588.359</ArticleId><ArticleId IdType="pmc">PMC1984892</ArticleId><ArticleId IdType="pubmed">15508206</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenstein MJ, Tilley WS, Sandler MP. The syndrome of hypothalamic hypopituitarism complicating viral meningoencephalitis. J Endocrinol Invest. (1982) 5:111&#x2013;5. doi:&#xa0;10.1007/BF03350501</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03350501</ArticleId><ArticleId IdType="pubmed">7096919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupari M, Pelkonen R, Valtonen V. Post-encephalitic hypothalamic-pituitary insufficiency. Acta Endocrinol (Copenh). (1980) 94:433&#x2013;8. doi:&#xa0;10.1530/acta.0.0940433</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/acta.0.0940433</ArticleId><ArticleId IdType="pubmed">7435109</ArticleId></ArticleIdList></Reference><Reference><Citation>Jew K, Piziak V, Gilliland PF, Hurley DL. Meningoencephalitis complicated by pituitary insufficiency and a spontaneously resolving suprasellar mass. Neurosurgery. (1984) 14:567&#x2013;9. doi:&#xa0;10.1227/00006123-198405000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1227/00006123-198405000-00008</ArticleId><ArticleId IdType="pubmed">6728163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ickenstein CW, Klotz JM, Langohr HD. [Virus encephalitis with symptomatic Parkinson syndrome, diabetes insipidus and panhypopituitarism]. Fortschr Neurol Psychiatr. (1999) 67:476&#x2013;81. doi:&#xa0;10.1055/s-2007-994998</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-994998</ArticleId><ArticleId IdType="pubmed">10596369</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslam RHA, Winternitz WW, Howieson J. Selective hypopituitarism following tuberculous menigitis. Am J Dis Child. (1969) 118:903&#x2013;8. doi:&#xa0;10.1001/archpedi.1969.02100040905017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1969.02100040905017</ArticleId><ArticleId IdType="pubmed">5353020</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;gg E, &#xc5;str&#xf6;m L, Steen L. Persistent hypothalamic-pituitary insufficiency following acute meningoencephalitis. Acta Med Scand. (1978) 203:231&#x2013;5. doi:&#xa0;10.1111/J.0954-6820.1978.TB14862.X</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.0954-6820.1978.TB14862.X</ArticleId><ArticleId IdType="pubmed">636918</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks MH, Dumlao JS, Bronsky D, Waldstein SS. Hypophysial tuberculoma with hypopituitarism. Am J Med. (1973) 54:777&#x2013;81. doi:&#xa0;10.1016/0002-9343(73)90065-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(73)90065-X</ArticleId><ArticleId IdType="pubmed">4705420</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarvainen M, M&#xe4;kel&#xe4; S, Mustonen J, Jaatinen P. Autoimmune polyendocrinopathy and hypophysitis after Puumala hantavirus infection. Endocrinol Diabetes Metab Case Rep. (2016) 2016:16-0084. doi:&#xa0;10.1530/EDM-16-0084</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EDM-16-0084</ArticleId><ArticleId IdType="pmc">PMC5097139</ArticleId><ArticleId IdType="pubmed">27857837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekic S, Popovic V. DIAGNOSIS OF ENDOCRINE DISEASE: Expanding the cause of hypopituitarism. Eur J Endocrinol. (2017) 176:R269&#x2013;82. doi:&#xa0;10.1530/EJE-16-1065</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-16-1065</ArticleId><ArticleId IdType="pubmed">28258131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubbi S, Hannah-Shmouni F, Verbalis JG, Koch CA. Hypophysitis: an update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Pract Res Clin Endocrinol Metab. (2019) 33:101371. doi:&#xa0;10.1016/j.beem.2019.101371</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2019.101371</ArticleId><ArticleId IdType="pmc">PMC7078033</ArticleId><ArticleId IdType="pubmed">31866206</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey JM, Broderick G, Bowie A, Barnes ZM, Katz BZ, O&#x2019;Gorman MRG, et al. . Tracking post-infectious fatigue in clinic using routine Lab tests. BMC Pediatr. (2016) 16:54. doi:&#xa0;10.1186/s12887-016-0596-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-016-0596-8</ArticleId><ArticleId IdType="pmc">PMC4847210</ArticleId><ArticleId IdType="pubmed">27118537</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias P, Biagetti B, Guerrero-P&#xe9;rez F, Vicente A, Cordido F, D&#xed;ez JJ. Executive summary of the consensus document on hypophysitis of the Neuroendocrinology Area of Knowledge of the Spanish Society of Endocrinology and Nutrition. Endocrinolog&#xed;a Diabetes y Nutrici&#xf3;n (English ed). (2023) 70:116&#x2013;25. doi:&#xa0;10.1016/j.endien.2023.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.endien.2023.01.001</ArticleId><ArticleId IdType="pubmed">36894450</ArticleId></ArticleIdList></Reference><Reference><Citation>
Pekic S, Miljic D, Popovic V. Infections of the hypothalamic-pituitary region, in: Endotext (2021). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK532083/ (Accessed March 14, 2024).</Citation></Reference><Reference><Citation>DosSantos MF, Holanda-Afonso RC, Lima RL, DaSilva AF, Moura-Neto V. The role of the blood&#x2013;brain barrier in the development and treatment of migraine and other pain disorders. Front Cell Neurosci. (2014) 8:302. doi:&#xa0;10.3389/fncel.2014.00302</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00302</ArticleId><ArticleId IdType="pmc">PMC4189386</ArticleId><ArticleId IdType="pubmed">25339863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur C, Ling EA. The circumventricular organs. Histol Histopathol. (2017) 32:879&#x2013;92. doi:&#xa0;10.14670/HH-11-881</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/HH-11-881</ArticleId><ArticleId IdType="pubmed">28177105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiecker C. The origins of the circumventricular organs. J Anat. (2018) 232:540. doi:&#xa0;10.1111/joa.12771</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12771</ArticleId><ArticleId IdType="pmc">PMC5835788</ArticleId><ArticleId IdType="pubmed">29280147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiloiro S, Russo F, Tartaglione T, Capoluongo ED. Molecular and genetic immune biomarkers of primary and immune-therapy induced hypophysitis: from laboratories to the clinical practice. J Pers Med. (2021) 11:1026. doi:&#xa0;10.3390/jpm11101026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11101026</ArticleId><ArticleId IdType="pmc">PMC8537090</ArticleId><ArticleId IdType="pubmed">34683167</ArticleId></ArticleIdList></Reference><Reference><Citation>Menotti S, Giampietro A, Raia S, Veleno M, Angelini F, Tartaglione T, et al. . Unveiling the etiopathogenic spectrum of hypophysitis: A narrative review. J Pers Med. (2023) 13:1210. doi:&#xa0;10.3390/jpm13081210</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm13081210</ArticleId><ArticleId IdType="pmc">PMC10455260</ArticleId><ArticleId IdType="pubmed">37623461</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenstein AE, Hunt HJ. The glucocorticoid receptor modulator relacorilant reverses the immunosuppressive effects of cortisol. Int Immunopharmacol. (2023) 120:110312. doi:&#xa0;10.1016/j.intimp.2023.110312</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2023.110312</ArticleId><ArticleId IdType="pubmed">37230031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fareau GG, Vassilopoulou-Sellin R. Hypercortisolemia and infection. Infect Dis Clin North Am. (2007) 21:639&#x2013;57. doi:&#xa0;10.1016/j.idc.2007.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2007.06.001</ArticleId><ArticleId IdType="pubmed">17826616</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its behavioral and metabolic correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. (2012) 1261:55. doi:&#xa0;10.1111/j.1749-6632.2012.06633.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2012.06633.x</ArticleId><ArticleId IdType="pmc">PMC3572859</ArticleId><ArticleId IdType="pubmed">22823394</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbuz MS, Rooney C, Jones M, Ingram CD. Hypothalamo-pituitary-adrenal axis responses to lipopolysaccharide in male and female rats with adjuvant-induced arthritis. Brain Behav Immun. (1999) 13:335&#x2013;47. doi:&#xa0;10.1006/brbi.1998.0536</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/brbi.1998.0536</ArticleId><ArticleId IdType="pubmed">10600220</ArticleId></ArticleIdList></Reference><Reference><Citation>Slominski RM, Tuckey RC, Manna PR, Jetten AM, Postlethwaite A, Raman C, et al. . Extra-adrenal glucocorticoid biosynthesis: Implications for autoimmune and inflammatory disorders. Genes Immun. (2020) 21:150. doi:&#xa0;10.1038/s41435-020-0096-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41435-020-0096-6</ArticleId><ArticleId IdType="pmc">PMC7276297</ArticleId><ArticleId IdType="pubmed">32203088</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MKS, Kwek DSK, Ng AWK, Ong KC, Kaw GJL, Lee LSU. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf). (2005) 63:197. doi:&#xa0;10.1111/j.1365-2265.2005.02325.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei L, Sun S, Zhang J, Zhu H, Xu Y, Ma Q, et al. . Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol. (2010) 88:723&#x2013;30. doi:&#xa0;10.1139/O10-022</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/O10-022</ArticleId><ArticleId IdType="pubmed">20651845</ArticleId></ArticleIdList></Reference><Reference><Citation>Ach T, Slama NBH, Gorchane A, Ben AA, Garma M, Ben LN, et al. . Explaining long COVID: A pioneer cross-sectional study supporting the endocrine hypothesis. J Endocr Soc. (2024) 8:bvae003. doi:&#xa0;10.1210/jendso/bvae003</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvae003</ArticleId><ArticleId IdType="pmc">PMC10801829</ArticleId><ArticleId IdType="pubmed">38260089</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazzi C, Villemure-Poliquin N, Nadeau S, Champagne PO. SARS-coV-2 infection, A risk factor for pituitary apoplexy? A case series and literature review. Ear Nose Throat J. (2023) 103(1_suppl):153S&#x2013;161S. doi:&#xa0;10.1177/01455613231179714</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613231179714</ArticleId><ArticleId IdType="pmc">PMC10261951</ArticleId><ArticleId IdType="pubmed">37291861</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonglait PL, Naik R, Raizada N. Hypophysitis after COVID-19 infection. Indian J Endocrinol Metab. (2021) 25:255. doi:&#xa0;10.4103/ijem.ijem_329_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijem.ijem_329_21</ArticleId><ArticleId IdType="pmc">PMC8547401</ArticleId><ArticleId IdType="pubmed">34760685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh AB, Javaid MA, Sheikh AAE, Shekhar R. Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report. Pan Afr Med J. (2021) 38:222. doi:&#xa0;10.11604/PAMJ.2021.38.222.28243</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/PAMJ.2021.38.222.28243</ArticleId><ArticleId IdType="pmc">PMC8140727</ArticleId><ArticleId IdType="pubmed">34046127</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbova NY, Vladimirova VP, Rozhinskaya LY, Belaya ZY. &#x41a;&#x43b;&#x438;&#x43d;&#x438;&#x447;&#x435;&#x441;&#x43a;&#x438;&#x439; &#x441;&#x43b;&#x443;&#x447;&#x430;&#x439; &#x433;&#x438;&#x43f;&#x43e;&#x43f;&#x438;&#x442;&#x443;&#x438;&#x442;&#x430;&#x440;&#x438;&#x437;&#x43c;&#x430; &#x432;&#x441;&#x43b;&#x435;&#x434;&#x441;&#x442;&#x432;&#x438;&#x435; &#x433;&#x438;&#x43f;&#x43e;&#x444;&#x438;&#x437;&#x438;&#x442;&#x430; &#x432; &#x43f;&#x435;&#x440;&#x438;&#x43e;&#x434;&#x435; &#x440;&#x435;&#x43a;&#x43e;&#x43d;&#x432;&#x430;&#x43b;&#x435;&#x441;&#x446;&#x435;&#x43d;&#x446;&#x438;&#x438; &#x43f;&#x43e;&#x441;&#x43b;&#x435; &#x43f;&#x435;&#x440;&#x435;&#x43d;&#x435;&#x441;&#x435;&#x43d;&#x43d;&#x43e;&#x439; &#x438;&#x43d;&#x444;&#x435;&#x43a;&#x446;&#x438;&#x438; COVID-19. Problems Endocrinol. (2022) 68:50. doi:&#xa0;10.14341/probl.2022683</Citation><ArticleIdList><ArticleId IdType="doi">10.14341/probl.2022683</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi M, Gunawardena S, Goenka A, Ey E, Kumar G. Post COVID-19 lymphocytic hypophysitis: A rare presentation. hild Neurol Open. (2022) 9:2329048X2211030. doi:&#xa0;10.1177/2329048X221103051</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2329048X221103051</ArticleId><ArticleId IdType="pmc">PMC9125064</ArticleId><ArticleId IdType="pubmed">35615060</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgar RA, Rasool A, Wani AI, Bashir MI. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection. J Endocrinol Invest. (2021) 44:2855. doi:&#xa0;10.1007/s40618-021-01627-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01627-z</ArticleId><ArticleId IdType="pmc">PMC8253675</ArticleId><ArticleId IdType="pubmed">34215999</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerrouki D, Assarrar I, Rami I, Rouf S, Latrech H. Coronavirus as a trigger of lymphocytic hypophysitis in an adolescent girl: An exceptional case report. Int J Surg Case Rep. (2024) 115:109218. doi:&#xa0;10.1016/j.ijscr.2023.109218</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijscr.2023.109218</ArticleId><ArticleId IdType="pmc">PMC10824777</ArticleId><ArticleId IdType="pubmed">38199020</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg MK, Gopalakrishnan M, Yadav P, Misra S. Endocrine involvement in COVID-19: mechanisms, clinical features, and implications for care. Indian J Endocrinol Metab. (2020) 24:381. doi:&#xa0;10.4103/ijem.IJEM_440_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijem.IJEM_440_20</ArticleId><ArticleId IdType="pmc">PMC7810055</ArticleId><ArticleId IdType="pubmed">33489841</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-coV-2&#x2019;s reliance on ACE2. Endocrinology. (2020) 161:bqaa108. doi:&#xa0;10.1210/endocr/bqaa108</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa108</ArticleId><ArticleId IdType="pmc">PMC7454499</ArticleId><ArticleId IdType="pubmed">32652001</ArticleId></ArticleIdList></Reference><Reference><Citation>Inaba H, Aizawa T. Coronavirus disease 2019 and the thyroid - progress and perspectives. Front Endocrinol (Lausanne). (2021) 12:708333/BIBTEX. doi:&#xa0;10.3389/FENDO.2021.708333/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2021.708333/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8279745</ArticleId><ArticleId IdType="pubmed">34276567</ArticleId></ArticleIdList></Reference><Reference><Citation>Churilov LP, Normatov MG, Utekhin VJ. Molecular mimicry between SARS-coV-2 and human endocrinocytes: A prerequisite of post-COVID-19 endocrine autoimmunity? Pathophysiology. (2022) 29:486. doi:&#xa0;10.3390/pathophysiology29030039</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29030039</ArticleId><ArticleId IdType="pmc">PMC9504401</ArticleId><ArticleId IdType="pubmed">36136066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Beuschlein F, Bornstein SR. Is there a role for the adrenal glands in long COVID? Nat Rev Endocrinol 2022 18:8. (2022) 18:451&#x2013;2. doi:&#xa0;10.1038/s41574-022-00700-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00700-8</ArticleId><ArticleId IdType="pmc">PMC9150041</ArticleId><ArticleId IdType="pubmed">35637413</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Torres D, D&#xed;az-Rodr&#xed;guez C, Armentia-Medina A. Anti-ACTH antibodies in critically ill Covid-19 patients: A potential immune evasion mechanism of SARS-CoV-2. Med Intensiva. (2022) 46:472&#x2013;4. doi:&#xa0;10.1016/j.medin.2021.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2021.09.002</ArticleId><ArticleId IdType="pmc">PMC8498650</ArticleId><ArticleId IdType="pubmed">34642524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatland R. Molecular mimicry of ACTH in SARS &#x2013; implications for corticosteroid treatment and prophylaxis. Med Hypotheses. (2004) 63:855. doi:&#xa0;10.1016/j.mehy.2004.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2004.04.009</ArticleId><ArticleId IdType="pmc">PMC7126000</ArticleId><ArticleId IdType="pubmed">15488660</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Anderson G, Maes M. Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol Neurobiol. (2017) 54:6806&#x2013;19. doi:&#xa0;10.1007/s12035-016-0170-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0170-2</ArticleId><ArticleId IdType="pubmed">27766535</ArticleId></ArticleIdList></Reference><Reference><Citation>Reincke M, Heppner C, Petzke F, Allolio B, Arlt W, Mbulamberi D, et al. . Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in african trypanosomiasis. Neuroimmunomodulation. (1994) 1:14&#x2013;22. doi:&#xa0;10.1159/000095930</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000095930</ArticleId><ArticleId IdType="pubmed">8528879</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaillard RC, Turnill D, Sappino P, Muller AF. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology. (1990) 127:101&#x2013;6. doi:&#xa0;10.1210/endo-127-1-101</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endo-127-1-101</ArticleId><ArticleId IdType="pubmed">2163305</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE. Critical illness-related corticosteroid insufficiency. Chest. (2009) 135:181&#x2013;93. doi:&#xa0;10.1378/chest.08-1149</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.08-1149</ArticleId><ArticleId IdType="pubmed">19136406</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Harding S, Sorenson M, Jason L, Maher K, Fletcher M, Reynolds N, et al. . The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome. J Appl Biobehav Res. (2008) 13:157&#x2013;80. doi:&#xa0;10.1111/j.1751-9861.2008.00033.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1751-9861.2008.00033.x</ArticleId><ArticleId IdType="pmc">PMC2730359</ArticleId><ArticleId IdType="pubmed">19701493</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijhof SL, Rutten JMTM, Uiterwaal CSPM, Bleijenberg G, Kimpen JLL, van de Putte EM. The role of hypocortisolism in chronic fatigue syndrome. Psychoneuroendocrinology. (2014) 42:199&#x2013;206. doi:&#xa0;10.1016/j.psyneuen.2014.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2014.01.017</ArticleId><ArticleId IdType="pubmed">24636516</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink ME, Roerink SHPP, Skoluda N, van der Schaaf ME, Hermus ARMM, van der Meer JWM, et al. . Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome. Horm Behav. (2018) 103:1&#x2013;6. doi:&#xa0;10.1016/j.yhbeh.2018.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yhbeh.2018.05.016</ArticleId><ArticleId IdType="pubmed">29807037</ArticleId></ArticleIdList></Reference><Reference><Citation>Herane-Vives A, Papadopoulos A, de Angel V, Chua KC, Soto L, Chalder T, et al. . Cortisol levels in chronic fatigue syndrome and atypical depression measured using hair and saliva specimens. J Affect Disord. (2020) 267:307&#x2013;14. doi:&#xa0;10.1016/j.jad.2020.01.146</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.01.146</ArticleId><ArticleId IdType="pubmed">32217231</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts ADL, Wessely S, Chalder T, Papadopoulos A, Cleare AJ. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry. (2004) 184:136&#x2013;41. doi:&#xa0;10.1192/bjp.184.2.136</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.184.2.136</ArticleId><ArticleId IdType="pubmed">14754825</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Newton J, Watson S. A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. ISRN Neurosci. (2013) 2013:1&#x2013;8. doi:&#xa0;10.1155/2013/784520</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/784520</ArticleId><ArticleId IdType="pmc">PMC4045534</ArticleId><ArticleId IdType="pubmed">24959566</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaab J, Engert V, Heitz V, SChad T, Sch&#xfc;rmeyer TH, Ehlert U. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. J Psychosom Res. (2004) 56:419&#x2013;24. doi:&#xa0;10.1016/S0022-3999(03)00625-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(03)00625-1</ArticleId><ArticleId IdType="pubmed">15094026</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S, Becker SC, Hartwig J, Sotzny F, Lorenz S, Bauer S, et al. . Autoimmunity-related risk variants in PTPN22 and CTLA4 are associated with ME/CFS with infectious onset. Front Immunol. (2020) 11:578/FULL. doi:&#xa0;10.3389/FIMMU.2020.00578/FULL</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2020.00578/FULL</ArticleId><ArticleId IdType="pmc">PMC7161310</ArticleId><ArticleId IdType="pubmed">32328064</ArticleId></ArticleIdList></Reference><Reference><Citation>Niller HH, Wolf H, Ay E, Minarovits J. Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease. Adv Exp Med Biol. (2011) 711:82&#x2013;102. doi:&#xa0;10.1007/978-1-4419-8216-2_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-8216-2_7</ArticleId><ArticleId IdType="pubmed">21627044</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkemade A, Friesema EC, Kuiper GG, Wiersinga WM, Swaab DF, Visser TJ, et al. . Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. Eur J Endocrinol. (2006) 154:491&#x2013;500. doi:&#xa0;10.1530/eje.1.02111</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje.1.02111</ArticleId><ArticleId IdType="pubmed">16498064</ArticleId></ArticleIdList></Reference><Reference><Citation>Glennon E, Kaunzner UW, Gagnidze K, McEwen BS, Bulloch K. Pituitary dendritic cells communicate immune pathogenic signals. Brain Behav Immun. (2015) 50:232&#x2013;40. doi:&#xa0;10.1016/j.bbi.2015.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.07.007</ArticleId><ArticleId IdType="pubmed">26188188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatland R. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic&#x2013;pituitary&#x2013;adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. Med Hypotheses. (2005) 65:287&#x2013;95. doi:&#xa0;10.1016/j.mehy.2005.02.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2005.02.031</ArticleId><ArticleId IdType="pubmed">15885924</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bellis A, Bellastella G, Pernice V, Cirillo P, Longo M, Maio A, et al. . Hypothalamic-pituitary autoimmunity and related impairment of hormone secretions in chronic fatigue syndrome. J Clin Endocrinol Metab. (2021) 106:e5147&#x2013;55. doi:&#xa0;10.1210/clinem/dgab429</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab429</ArticleId><ArticleId IdType="pubmed">34254637</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bellis A, Dello Iacovo A, Bellastella G, Savoia A, Cozzolino D, Sinisi AA, et al. . Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism. Pituitary. (2014) 17:457&#x2013;63. doi:&#xa0;10.1007/S11102-013-0526-9/TABLES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11102-013-0526-9/TABLES/3</ArticleId><ArticleId IdType="pubmed">24122272</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba V, Malkova A, Basantsova N, Halpert G, Andreoli L, Tincani A, et al. . Classical examples of the concept of the ASIA syndrome. Biomolecules. (2020) 10:1&#x2013;17. doi:&#xa0;10.3390/biom10101436</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10101436</ArticleId><ArticleId IdType="pmc">PMC7600067</ArticleId><ArticleId IdType="pubmed">33053910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara LJ, Vera-Lastra O, Mahroum N, Pineda C, Shoenfeld Y. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand? Clin Rheumatol. (2022) 41:1603. doi:&#xa0;10.1007/s10067-022-06149-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06149-4</ArticleId><ArticleId IdType="pmc">PMC8979721</ArticleId><ArticleId IdType="pubmed">35378658</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A, Sharif K, Shoenfeld Y. The ASIA syndrome: basic concepts. Mediterr J Rheumatol. (2017) 28:64. doi:&#xa0;10.31138/mjr</Citation><ArticleIdList><ArticleId IdType="doi">10.31138/mjr</ArticleId><ArticleId IdType="pmc">PMC7046028</ArticleId><ArticleId IdType="pubmed">32185259</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Yao Z, Zhou X, Zhang W, Zhang X, Zhang F. Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation. Clin Immunol. (2020) 213:108377. doi:&#xa0;10.1016/j.clim.2020.108377</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108377</ArticleId><ArticleId IdType="pubmed">32135278</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzarella L, Duso BA, Trapani D, Belli C, D&#x2019;Amico P, Ferraro E, et al. . The evolving landscape of &#x201c;next-generation&#x201d; immune checkpoint inhibitors: A review. Eur J Cancer. (2019) 117:14&#x2013;31. doi:&#xa0;10.1016/j.ejca.2019.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2019.04.035</ArticleId><ArticleId IdType="pubmed">31229946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibis B, Aliazis K, Cao C, Yenyuwadee S, Boussiotis VA. Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases. Front Immunol. (2023) 14:1197364. doi:&#xa0;10.3389/fimmu.2023.1197364</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1197364</ArticleId><ArticleId IdType="pmc">PMC10277501</ArticleId><ArticleId IdType="pubmed">37342323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahzari M, Liu D, Arnaout A, Lochnan H. Immune checkpoint inhibitor therapy associated hypophysitis. Clin Med Insights Endocrinol Diabetes. (2015) 8:21&#x2013;8. doi:&#xa0;10.4137/CMED.S22469/ASSET/IMAGES/LARGE/10.4137_CMED.S22469-FIG2.JPEG</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/CMED.S22469/ASSET/IMAGES/LARGE/10.4137_CMED.S22469-FIG2.JPEG</ArticleId><ArticleId IdType="pmc">PMC4376202</ArticleId><ArticleId IdType="pubmed">25861234</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinnis GJ, Raber J. CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy. Immunotherapy. (2017) 9:929. doi:&#xa0;10.2217/imt-2017-0056</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt-2017-0056</ArticleId><ArticleId IdType="pmc">PMC6161123</ArticleId><ArticleId IdType="pubmed">29338610</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun DJ, Wolchok JD, Rosenberg LM, Girotra M. Cancer immunotherapy&#x2014;immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol. (2017) 13:195. doi:&#xa0;10.1038/nrendo.2016.205</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2016.205</ArticleId><ArticleId IdType="pmc">PMC5629093</ArticleId><ArticleId IdType="pubmed">28106152</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong T, Zhi L, Bhayana B, Wu MX. Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury. J Neuroinflamm. (2016) 13:197. doi:&#xa0;10.1186/s12974-016-0663-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0663-y</ArticleId><ArticleId IdType="pmc">PMC5000452</ArticleId><ArticleId IdType="pubmed">27561600</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson S, Moran P, Epel E, Sinclair E, Kemeny ME, Deeks SG, et al. . Cortisol patterns are associated with T cell activation in HIV. PloS One. (2013) 8:63429. doi:&#xa0;10.1371/journal.pone.0063429</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063429</ArticleId><ArticleId IdType="pmc">PMC3724863</ArticleId><ArticleId IdType="pubmed">23922644</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Zhu H, Wang X, Jing B, Li Z, Xia X, et al. . Adjuvants for coronavirus vaccines. Front Immunol. (2020) 11:589833. doi:&#xa0;10.3389/fimmu.2020.589833</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589833</ArticleId><ArticleId IdType="pmc">PMC7677582</ArticleId><ArticleId IdType="pubmed">33240278</ArticleId></ArticleIdList></Reference><Reference><Citation>Barajas Galindo DE, Ramos Bachiller B, Gonz&#xe1;lez Roza L, Garc&#xed;a Ruiz de Morales JM, S&#xe1;nchez Lasheras F, Gonz&#xe1;lez Arn&#xe1;iz E, et al. . Increased incidence of Graves&#x2019; disease during the SARS-CoV2 pandemic. Clin Endocrinol (Oxf). (2023) 98:730&#x2013;7. doi:&#xa0;10.1111/cen.14860</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14860</ArticleId><ArticleId IdType="pmc">PMC9877771</ArticleId><ArticleId IdType="pubmed">36510647</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen Tervaert JW, Martinez-Lavin M, Jara LJ, Halpert G, Watad A, Amital H, et al. . Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023. Autoimmun Rev. (2023) 22:103287. doi:&#xa0;10.1016/j.autrev.2023.103287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2023.103287</ArticleId><ArticleId IdType="pubmed">36738954</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri RM, Giovanellla L, Campenn&#xec; A. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature. J Endocrinol Invest. (2022) 45:2283. doi:&#xa0;10.1007/s40618-022-01863-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01863-x</ArticleId><ArticleId IdType="pmc">PMC9277984</ArticleId><ArticleId IdType="pubmed">35829989</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita S, Tsuji T, Kishimoto S, Uraki S, Takeshima K, Iwakura H, et al. . Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report. BMC Endocr Disord. (2022) 22:1&#x2013;6. doi:&#xa0;10.1186/S12902-022-01095-3/FIGURES/2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12902-022-01095-3/FIGURES/2</ArticleId><ArticleId IdType="pmc">PMC9297640</ArticleId><ArticleId IdType="pubmed">35854260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ankireddypalli AR, Chow LS, Radulescu A, Kawakami Y, Araki T. A case of hypophysitis associated with SARS-coV-2 vaccination. AACE Clin Case Rep. (2022) 8:204. doi:&#xa0;10.1016/j.aace.2022.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aace.2022.06.001</ArticleId><ArticleId IdType="pmc">PMC9212943</ArticleId><ArticleId IdType="pubmed">35754921</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzaioli LC, Gatta E, Bambini F, Facondo P, Gava M, Cavadini M, et al. . Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature. Front Endocrinol (Lausanne). (2022) 13:1027047/BIBTEX. doi:&#xa0;10.3389/FENDO.2022.1027047/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2022.1027047/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC9685624</ArticleId><ArticleId IdType="pubmed">36440218</ArticleId></ArticleIdList></Reference><Reference><Citation>Murvelashvili N, Tessnow A. A case of hypophysitis following immunization with the mRNA-1273 SARS-coV-2 vaccine. J Investig Med High Impact Case Rep. (2021) 9:23247096211043386. doi:&#xa0;10.1177/23247096211043386</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23247096211043386</ArticleId><ArticleId IdType="pmc">PMC8474296</ArticleId><ArticleId IdType="pubmed">34553641</ArticleId></ArticleIdList></Reference><Reference><Citation>Taieb A, Mounira EE, Redwan M, Chavda VP, Apostolopoulos V, Taieb A, et al. . Pilot findings on SARS-coV-2 vaccine-induced pituitary diseases: A mini review from diagnosis to pathophysiology. Vaccines 2022 Vol 10 Page 2004. (2022) 10:2004. doi:&#xa0;10.3390/vaccines10122004</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10122004</ArticleId><ArticleId IdType="pmc">PMC9786744</ArticleId><ArticleId IdType="pubmed">36560413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishay A, Shacham EC. Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine? BMC Endocr Disord. (2023) 23:1&#x2013;6. doi:&#xa0;10.1186/S12902-023-01296-4/FIGURES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12902-023-01296-4/FIGURES/1</ArticleId><ArticleId IdType="pmc">PMC9945387</ArticleId><ArticleId IdType="pubmed">36810011</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz FX, Stiasny K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. NPJ Vaccines 2021 6:1. (2021) 6:1&#x2013;13. doi:&#xa0;10.1038/s41541-021-00369-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-021-00369-6</ArticleId><ArticleId IdType="pmc">PMC8368295</ArticleId><ArticleId IdType="pubmed">34400651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YH, Beiss V, Fiering SN, Steinmetz NF. Covid-19 vaccine frontrunners and their nanotechnology design. ACS Nano. (2020) 14:12522&#x2013;37. doi:&#xa0;10.1021/ACSNANO.0C07197/ASSET/IMAGES/MEDIUM/NN0C07197_0004.GIF</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ACSNANO.0C07197/ASSET/IMAGES/MEDIUM/NN0C07197_0004.GIF</ArticleId><ArticleId IdType="pubmed">33034449</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavda VP, Bezbaruah R, Valu D, Patel B, Kumar A, Prasad S, et al. . Adenoviral vector-based vaccine platform for COVID-19: current status. Vaccines (Basel). (2023) 11:432. doi:&#xa0;10.3390/vaccines11020432</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020432</ArticleId><ArticleId IdType="pmc">PMC9965371</ArticleId><ArticleId IdType="pubmed">36851309</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan L. Factors which contribute to the immunogenicity of non-replicating adenoviral vectored vaccines. Front Immunol. (2020) 11:909. doi:&#xa0;10.3389/fimmu.2020.00909</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00909</ArticleId><ArticleId IdType="pmc">PMC7248264</ArticleId><ArticleId IdType="pubmed">32508823</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, et al. . Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood. (2007) 110:1916&#x2013;23. doi:&#xa0;10.1182/blood-2007-02-062117</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-02-062117</ArticleId><ArticleId IdType="pmc">PMC1976365</ArticleId><ArticleId IdType="pubmed">17510320</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discovery. (2018) 17:261&#x2013;79. doi:&#xa0;10.1038/nrd.2017.243</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.243</ArticleId><ArticleId IdType="pmc">PMC5906799</ArticleId><ArticleId IdType="pubmed">29326426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsiambas E, Chrysovergis A, Papanikolaou V, Mastronikolis N, Ragos V, Batistatou A, et al. . Impact of ribosome activity on SARS-coV-2 LNP - based mRNA vaccines. Front Mol Biosci. (2021) 8:654866. doi:&#xa0;10.3389/fmolb.2021.654866</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.654866</ArticleId><ArticleId IdType="pmc">PMC8093617</ArticleId><ArticleId IdType="pubmed">33959636</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt T, Klemis V, Schub D, Schneitler S, Reichert MC, Wilkens H, et al. . Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients. Am J Transplant. (2021) 21:3990&#x2013;4002. doi:&#xa0;10.1111/ajt.16818</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16818</ArticleId><ArticleId IdType="pmc">PMC8652989</ArticleId><ArticleId IdType="pubmed">34453872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Yin J, Miller AH, Xiao C. A systematic review of the association between fatigue and genetic polymorphisms. Brain Behav Immun. (2017) 62:230. doi:&#xa0;10.1016/j.bbi.2017.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.01.007</ArticleId><ArticleId IdType="pmc">PMC5947855</ArticleId><ArticleId IdType="pubmed">28089639</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J, Fritz EL, Kerr JR, Cleare AJ, Wessely S, Mattey DL. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J Clin Pathol. (2005) 58:860&#x2013;3. doi:&#xa0;10.1136/jcp.2004.022681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2004.022681</ArticleId><ArticleId IdType="pmc">PMC1770867</ArticleId><ArticleId IdType="pubmed">16049290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande A, Fluge &#xd8;, Strand EB, Fl&#xe5;m ST, Sosa DD, Mella O, et al. . Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Sci Rep. (2020) 10:5267. doi:&#xa0;10.1038/s41598-020-62157-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62157-x</ArticleId><ArticleId IdType="pmc">PMC7093502</ArticleId><ArticleId IdType="pubmed">32210306</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller RH, Lane JL, Klimas N, Reiter WM, Fletcher MA, van Riel F, et al. . Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome. Clin Infect Dis. (1994) 18 Suppl 1:S154&#x2013;6. doi:&#xa0;10.1093/clinids/18.Supplement_1.S154</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/18.Supplement_1.S154</ArticleId><ArticleId IdType="pubmed">8148444</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill JA, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenetics. (2001) 28:425&#x2013;8. doi:&#xa0;10.1046/j.1365-2370.2001.00235.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2370.2001.00235.x</ArticleId><ArticleId IdType="pubmed">11422420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodis G, Toth V, Schwarting A. Role of human leukocyte antigens (HLA) in autoimmune diseases. Rheumatol Ther. (2018) 5:5. doi:&#xa0;10.1007/s40744-018-0100-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40744-018-0100-z</ArticleId><ArticleId IdType="pmc">PMC5935613</ArticleId><ArticleId IdType="pubmed">29516402</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango MT, Perricone C, Kivity S, Cipriano E, Ceccarelli F, Valesini G, et al. . HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol Res. (2017) 65:82&#x2013;98. doi:&#xa0;10.1007/s12026-016-8817-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8817-7</ArticleId><ArticleId IdType="pubmed">27435705</ArticleId></ArticleIdList></Reference><Reference><Citation>Helbig KJ, Heatley SL, Harris RJ, Mullighan CG, Bardy PG, Marmion BP. Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome. Genes Immun. (2003) 4:82&#x2013;5. doi:&#xa0;10.1038/sj.gene.6363912</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6363912</ArticleId><ArticleId IdType="pubmed">12595908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A. Epstein-barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front Immunol. (2021) 12:656797/BIBTEX. doi:&#xa0;10.3389/FIMMU.2021.656797/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.656797/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan MS, Smith AK, Dimulescu I, Unger ER, Vernon SD, Heim C, et al. . Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav. (2007) 6:167&#x2013;76. doi:&#xa0;10.1111/j.1601-183X.2006.00244.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1601-183X.2006.00244.x</ArticleId><ArticleId IdType="pubmed">16740143</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Cho S, Kim K, Park T. An integrated approach to infer causal associations among gene expression, genotype variation, and disease. Genomics. (2009) 94:269&#x2013;77. doi:&#xa0;10.1016/j.ygeno.2009.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2009.06.002</ArticleId><ArticleId IdType="pubmed">19540336</ArticleId></ArticleIdList></Reference><Reference><Citation>Caravantes-Cortes MI, Roldan-Valadez E, Zwojewski-Martinez RD, Salazar-Ruiz SY, Carballo-Zarate AA. Breast prosthesis syndrome: pathophysiology and management algorithm. Aesthetic Plast Surg. (2020) 44:1423&#x2013;37. doi:&#xa0;10.1007/s00266-020-01663-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00266-020-01663-9</ArticleId><ArticleId IdType="pubmed">32152711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Iwama S, Sugiyama D, Yasuda Y, Okuji T, Ito M, et al. . Original research: Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors. J Immunother Cancer. (2021) 9:2493. doi:&#xa0;10.1136/jitc-2021-002493</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2021-002493</ArticleId><ArticleId IdType="pmc">PMC8137231</ArticleId><ArticleId IdType="pubmed">34011534</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano A, Nesher G, Shoenfeld Y. Predicting post-vaccination autoimmunity: Who might be at risk? Pharmacol Res. (2015) 92:18&#x2013;22. doi:&#xa0;10.1016/j.phrs.2014.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2014.08.002</ArticleId><ArticleId IdType="pubmed">25277820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell LA, Tingle AJ, MacWilliam L, Home C, Keown P, Gaur LK, et al. . HLA-DR class II associations with rubella vaccine-induced joint manifestations. J Infect Dis. (1998) 177:5&#x2013;12. doi:&#xa0;10.1086/513807</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/513807</ArticleId><ArticleId IdType="pubmed">9419163</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Bautista JF, Sampedro A, G&#xf3;mez-Vicente E, Rodr&#xed;guez-Granger J, Reguera JA, Cobo F, et al. . HLA class II polymorphism and humoral immunity induced by the SARS-coV-2 mRNA-1273 vaccine. Vaccines (Basel). (2022) 10:402. doi:&#xa0;10.3390/VACCINES10030402/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES10030402/S1</ArticleId><ArticleId IdType="pmc">PMC8949280</ArticleId><ArticleId IdType="pubmed">35335034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentzer AJ, O&#x2019;Connor D, Bibi S, Chelysheva I, Clutterbuck EA, Demissie T, et al. . Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nat Med 2023 29:1. (2022) 29:147&#x2013;57. doi:&#xa0;10.1038/s41591-022-02078-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02078-6</ArticleId><ArticleId IdType="pmc">PMC9873562</ArticleId><ArticleId IdType="pubmed">36228659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragone C, Meola S, Fiorillo PC, Penta R, Auriemma L, Tornesello ML, et al. . HLA does not impact on short-medium-term antibody response to preventive anti-SARS-cov-2 vaccine. Front Immunol. (2021) 12:734689. doi:&#xa0;10.3389/fimmu.2021.734689</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.734689</ArticleId><ArticleId IdType="pmc">PMC8353253</ArticleId><ArticleId IdType="pubmed">34386018</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertinetto FE, Magistroni P, Mazzola GA, Costa C, Elena G, Alizzi S, et al. . The humoral and cellular response to mRNA SARS-CoV-2 vaccine is influenced by HLA polymorphisms. HLA. (2023) 102:301&#x2013;15. doi:&#xa0;10.1111/tan.15049</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.15049</ArticleId><ArticleId IdType="pubmed">37010080</ArticleId></ArticleIdList></Reference><Reference><Citation>Astbury S, Reynolds CJ, Butler DK, Mu&#xf1;oz-Sandoval DC, Lin KM, Pieper FP, et al. . HLA-DR polymorphism in SARS-CoV-2 infection and susceptibility to symptomatic COVID-19. Immunology. (2022) 166:68&#x2013;77. doi:&#xa0;10.1111/imm.13450</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13450</ArticleId><ArticleId IdType="pmc">PMC9111350</ArticleId><ArticleId IdType="pubmed">35156709</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli A, Andreani M, Biancolella M, Liberatoscioli L, Passarelli C, Colona VL, et al. . HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. (2020) 96:610&#x2013;4. doi:&#xa0;10.1111/tan.14047</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tan.14047</ArticleId><ArticleId IdType="pmc">PMC7461491</ArticleId><ArticleId IdType="pubmed">32827207</ArticleId></ArticleIdList></Reference><Reference><Citation>Troshina E, Yukina M, Nuralieva N, Vasilyev E, Rebrova O, Akhmatova R, et al. . Association of alleles of human leukocyte antigen class II genes and severity of COVID-19 in patients of the &#x2018;Red zone&#x2019; of the endocrinology research center, moscow, Russia. Diseases. (2022) 10:99. doi:&#xa0;10.3390/diseases10040099</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases10040099</ArticleId><ArticleId IdType="pmc">PMC9680278</ArticleId><ArticleId IdType="pubmed">36412593</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalam AK, Taneja V, David CS. HLA class II molecules influence susceptibility vs protection in inflammatory diseases by determining the cytokine profile. J Immunol. (2013) 190:513. doi:&#xa0;10.4049/jimmunol.1201891</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201891</ArticleId><ArticleId IdType="pmc">PMC3545203</ArticleId><ArticleId IdType="pubmed">23293357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bontrop RE, Otting N, De Groot NG, Doxiadis GGM. Major histocompatibility complex class II polymorphisms in primates. Immunol Rev. (1999) 167:339&#x2013;50. doi:&#xa0;10.1111/j.1600-065X.1999.tb01403.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.1999.tb01403.x</ArticleId><ArticleId IdType="pubmed">10319272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalam AK, Taneja V, David CS. HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile. J Immunol. (2013) 190:513&#x2013;9. doi:&#xa0;10.4049/jimmunol.1201891</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201891</ArticleId><ArticleId IdType="pmc">PMC3545203</ArticleId><ArticleId IdType="pubmed">23293357</ArticleId></ArticleIdList></Reference><Reference><Citation>Talotta R. Molecular mimicry and HLA polymorphisms may drive autoimmunity in recipients of the BNT-162b2 mRNA vaccine: A computational analysis. Microorganisms. (2023) 11:1686. doi:&#xa0;10.3390/MICROORGANISMS11071686/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MICROORGANISMS11071686/S1</ArticleId><ArticleId IdType="pmc">PMC10384367</ArticleId><ArticleId IdType="pubmed">37512859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lio D, Caccamo N, D&#x2019;Anna C, Cigna D, Candore G. Viral antibody titers are influenced by HLA-DR2 phenotype - PubMed. Exp Clin Immunogenet. (1994) 11:182&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7857663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou D, Chong P, Tripet B, Gilliam S. Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides. J Virol. (1992) 66:1674&#x2013;81. doi:&#xa0;10.1128/jvi.66.3.1674-1681.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.66.3.1674-1681.1992</ArticleId><ArticleId IdType="pmc">PMC240908</ArticleId><ArticleId IdType="pubmed">1371169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilonen J, Salmi A. Comparison of HLA-Dw1 and -Dw2 positive adherent cells in antigen presentation to heterozygous T-cell lines: a low rubella antigen&#x2013;specific response associated with HLA-Dw2. Hum Immunol. (1986) 17:94&#x2013;101. doi:&#xa0;10.1016/0198-8859(86)90079-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0198-8859(86)90079-0</ArticleId><ArticleId IdType="pubmed">2428786</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries RRP, Schreuder G, Naipal A, D&#x2019;Amaro J, van Rood JJ. Selection by typhoid and yellow fever epidemics witnessed by the HLA-DR locus. Immunobiology HLA. (1989) 2:461&#x2013;2. doi:&#xa0;10.1007/978-3-662-39946-0_193</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-662-39946-0_193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaslow RA, Shaw S. The role of histocompatibility antigens (HLA) in infection. Epidemiol Rev. (1981) 3:90&#x2013;114. doi:&#xa0;10.1093/oxfordjournals.epirev.a036241</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.epirev.a036241</ArticleId><ArticleId IdType="pubmed">7030765</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson T. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis. Eur J Immunol. (2021) 51:56&#x2013;9. doi:&#xa0;10.1002/eji.202049030</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202049030</ArticleId><ArticleId IdType="pmc">PMC7839707</ArticleId><ArticleId IdType="pubmed">33350470</ArticleId></ArticleIdList></Reference><Reference><Citation>Zdimerova H, Murer A, Engelmann C, Raykova A, Deng Y, Gujer C, et al. . Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15. Eur J Immunol. (2021) 51:64&#x2013;75. doi:&#xa0;10.1002/eji.202048655</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048655</ArticleId><ArticleId IdType="pubmed">32949466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M. CD4+ Cytotoxic T cells involved in the development of EBV-associated diseases. Pathog 2022 Vol 11 Page 831. (2022) 11:831. doi:&#xa0;10.3390/pathogens11080831</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11080831</ArticleId><ArticleId IdType="pmc">PMC9330826</ArticleId><ArticleId IdType="pubmed">35894054</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung CS, Haigh TA, Mackay LK, Rickinson AB, Taylor GS. Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc Natl Acad Sci U.S.A. (2010) 107:2165&#x2013;70. doi:&#xa0;10.1073/pnas.0909448107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0909448107</ArticleId><ArticleId IdType="pmc">PMC2836662</ArticleId><ArticleId IdType="pubmed">20133861</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nz C, Bickham KL, Subklewe M, Tsang ML, Chahroudi A, Kurilla MG, et al. . Human CD4+ T lymphocytes consistently respond to the latent Epstein- Barr virus nuclear antigen EBNA1. J Exp Med. (2000) 191:1649&#x2013;60. doi:&#xa0;10.1084/jem.191.10.1649</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.191.10.1649</ArticleId><ArticleId IdType="pmc">PMC2193162</ArticleId><ArticleId IdType="pubmed">10811859</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraro E, Merlo A, Martorelli D, Cangemi M, Santa SD, Dolcetti R, et al. . Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells. Front Immunol. (2017) 8:197. doi:&#xa0;10.3389/fimmu.2017.00197</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00197</ArticleId><ArticleId IdType="pmc">PMC5327441</ArticleId><ArticleId IdType="pubmed">28289418</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Perdomo MF, Kantele A, Hedman L, Hedman K, Franssila R. Granzyme B mediated function of Parvovirus B19-specific CD4+ T cells. Clin Transl Immunol. (2015) 4:e39. doi:&#xa0;10.1038/cti.2015.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2015.13</ArticleId><ArticleId IdType="pmc">PMC4524951</ArticleId><ArticleId IdType="pubmed">26246896</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton S, Mandaric S, Oxenius A. CD4 T cell responses in latent and chronic viral infections. Front Immunol. (2013) 4:105/XML/NLM. doi:&#xa0;10.3389/FIMMU.2013.00105/XML/NLM</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2013.00105/XML/NLM</ArticleId><ArticleId IdType="pmc">PMC3651995</ArticleId><ArticleId IdType="pubmed">23717308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Zabaleta A. Epstein&#x2013;Barr virus-acquired immunodeficiency in myalgic encephalomyelitis&#x2014;Is it present in long COVID? J Transl Med. (2023) 21:633. doi:&#xa0;10.1186/s12967-023-04515-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04515-7</ArticleId><ArticleId IdType="pmc">PMC10506247</ArticleId><ArticleId IdType="pubmed">37718435</ArticleId></ArticleIdList></Reference><Reference><Citation>Croia C, Astorri E, Murray-Brown W, Willis A, Brokstad KA, Sutcliffe N, et al. . Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj&#xf6;gren&#x2019;s syndrome. Arthritis Rheumatol. (2014) 66:2545&#x2013;57. doi:&#xa0;10.1002/art.38726</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38726</ArticleId><ArticleId IdType="pubmed">24891330</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, et al. . Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med. (2007) 204:2899. doi:&#xa0;10.1084/jem.20071030</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20071030</ArticleId><ArticleId IdType="pmc">PMC2118531</ArticleId><ArticleId IdType="pubmed">17984305</ArticleId></ArticleIdList></Reference><Reference><Citation>Croia C, Serafini B, Bombardieri M, Kelly S, Humby F, Severa M, et al. . Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis. (2013) 72:1559&#x2013;68. doi:&#xa0;10.1136/annrheumdis-2012-202352</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-202352</ArticleId><ArticleId IdType="pubmed">23268369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchesi D, Bombardieri M. The role of viruses in autoreactive B cell activation within tertiary lymphoid structures in autoimmune diseases. J Leukoc Biol. (2013) 94:1191&#x2013;9. doi:&#xa0;10.1189/jlb.0413240</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0413240</ArticleId><ArticleId IdType="pubmed">23812327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza ME, Cox B, Martinez B, Mena-Palomo I, Zarate GJ, Williams MV. Viral dUTPases: modulators of innate immunity. Biomolecules. (2022) 12:227. doi:&#xa0;10.3390/biom12020227</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12020227</ArticleId><ArticleId IdType="pmc">PMC8961515</ArticleId><ArticleId IdType="pubmed">35204728</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco F, Jaccard A, Romero P, Yu YR, Ho PC. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. (2020) 2:1001&#x2013;12. doi:&#xa0;10.1038/s42255-020-00280-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00280-9</ArticleId><ArticleId IdType="pubmed">32958939</ArticleId></ArticleIdList></Reference><Reference><Citation>Watowich MB, Gilbert MR, Larion M. T cell exhaustion in Malignant gliomas. Trends Cancer. (2023) 9:270&#x2013;92. doi:&#xa0;10.1016/j.trecan.2022.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trecan.2022.12.008</ArticleId><ArticleId IdType="pmc">PMC10038906</ArticleId><ArticleId IdType="pubmed">36681605</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, Seya T, et al. . Epstein-Barr virus (EBV)&#x2013;encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. J Exp Med. (2009) 206:2091&#x2013;9. doi:&#xa0;10.1084/jem.20081761</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20081761</ArticleId><ArticleId IdType="pmc">PMC2757889</ArticleId><ArticleId IdType="pubmed">19720839</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MV, Mena-Palomo I, Cox B, Ariza ME. EBV dUTPase: A novel modulator of inflammation and the tumor microenvironment in EBV-associated Malignancies. Cancers (Basel). (2023) 15:855. doi:&#xa0;10.3390/cancers15030855</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15030855</ArticleId><ArticleId IdType="pmc">PMC9913121</ArticleId><ArticleId IdType="pubmed">36765813</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliyari SR, Quanquin N, Pernet O, Zhang S, Wang L, Cheng G. The evolutionary dance between innate host antiviral pathways and SARS-coV-2. Pathogens. (2022) 11:538. doi:&#xa0;10.3390/pathogens11050538</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11050538</ArticleId><ArticleId IdType="pmc">PMC9147806</ArticleId><ArticleId IdType="pubmed">35631059</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani S, Oliviero B, Varchetta S, Renieri A, Mondelli MU. TLRs: innate immune sentries against SARS-coV-2 infection. Int J Mol Sci. (2023) 24:8065. doi:&#xa0;10.3390/ijms24098065</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098065</ArticleId><ArticleId IdType="pmc">PMC10178469</ArticleId><ArticleId IdType="pubmed">37175768</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S, Kothari H, Bosmann M. Tissue factor in COVID-19-associated coagulopathy. Thromb Res. (2022) 220:35. doi:&#xa0;10.1016/j.thromres.2022.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.09.025</ArticleId><ArticleId IdType="pmc">PMC9525243</ArticleId><ArticleId IdType="pubmed">36265412</ArticleId></ArticleIdList></Reference><Reference><Citation>Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. (2013) 39:633. doi:&#xa0;10.1016/j.immuni.2013.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.10.001</ArticleId><ArticleId IdType="pmc">PMC4012895</ArticleId><ArticleId IdType="pubmed">24138880</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghbash PS, Eslami N, Shamekh A, Entezari-Maleki T, Baghi HB. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis. Life Sci. (2021) 270:119124. doi:&#xa0;10.1016/j.lfs.2021.119124</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119124</ArticleId><ArticleId IdType="pmc">PMC7838580</ArticleId><ArticleId IdType="pubmed">33508291</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. . Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. (2020) 11:827/FULL. doi:&#xa0;10.3389/FIMMU.2020.00827/FULL</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2020.00827/FULL</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. . Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. (2020) 130:4694. doi:&#xa0;10.1172/JCI138554</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138554</ArticleId><ArticleId IdType="pmc">PMC7456250</ArticleId><ArticleId IdType="pubmed">32463803</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflammation Res. (2014) 63:803. doi:&#xa0;10.1007/s00011-014-0755-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0755-z</ArticleId><ArticleId IdType="pmc">PMC4160567</ArticleId><ArticleId IdType="pubmed">25048990</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher SA, Rahimzadeh M, Brierley C, Gration B, Doree C, Kimber CE, et al. . The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review. PloS One. (2019) 14:e0222313. doi:&#xa0;10.1371/journal.pone.0222313</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0222313</ArticleId><ArticleId IdType="pmc">PMC6759203</ArticleId><ArticleId IdType="pubmed">31550254</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Gong R, Luo G, Wang M, Li D, Chen Y, et al. . Association between vitamin D3 levels and insulin resistance: a large sample cross-sectional study. Sci Rep 2022 12:1. (2022) 12:1&#x2013;10. doi:&#xa0;10.1038/s41598-021-04109-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04109-7</ArticleId><ArticleId IdType="pmc">PMC8741779</ArticleId><ArticleId IdType="pubmed">34997087</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels I, Maywald M, Rink L. Zinc as a gatekeeper of immune function. Nutrients 2017 Vol 9 Page 1286. (2017) 9:1286. doi:&#xa0;10.3390/nu9121286</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9121286</ArticleId><ArticleId IdType="pmc">PMC5748737</ArticleId><ArticleId IdType="pubmed">29186856</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai H, Wang L, Li L, Huang Z, Ye L. Metallothionein 1: A new spotlight on inflammatory diseases. Front Immunol. (2021) 12:739918. doi:&#xa0;10.3389/fimmu.2021.739918</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.739918</ArticleId><ArticleId IdType="pmc">PMC8602684</ArticleId><ArticleId IdType="pubmed">34804020</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatineni V, An JY, Leffew MR, Mahesh SA. Anemia from A to zinc: Hypocupremia in the setting of gastric bypass and zinc excess. Clin Case Rep. (2020) 8:745&#x2013;50. doi:&#xa0;10.1002/ccr3.2741</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.2741</ArticleId><ArticleId IdType="pmc">PMC7141722</ArticleId><ArticleId IdType="pubmed">32274050</ArticleId></ArticleIdList></Reference><Reference><Citation>Prohaska JR. Impact of copper limitation on expression and function of multicopper oxidases (Ferroxidases). Adv Nutr. (2011) 2:89. doi:&#xa0;10.3945/an.110.000208</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.110.000208</ArticleId><ArticleId IdType="pmc">PMC3065751</ArticleId><ArticleId IdType="pubmed">22332037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehoe CA, Faughnan MS, Gilmore WS, Coulter JS, Howard AN, Strain JJ. Plasma diamine oxidase activity is greater in copper-adequate than copper-marginal or copper-deficient rats. J Nutr. (2000) 130:30&#x2013;3. doi:&#xa0;10.1093/jn/130.1.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/130.1.30</ArticleId><ArticleId IdType="pubmed">10613762</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Delivery Rev. (2008) 60:1527. doi:&#xa0;10.1016/j.addr.2008.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2008.06.002</ArticleId><ArticleId IdType="pmc">PMC2630537</ArticleId><ArticleId IdType="pubmed">18652859</ArticleId></ArticleIdList></Reference><Reference><Citation>Comas-Bast&#xe9; O, S&#xe1;nchez-P&#xe9;rez S, Veciana-Nogu&#xe9;s MT, Latorre-Moratalla M, Vidal-Carou MDC. Histamine intolerance: the current state of the art. Biomolecules. (2020) 10:1&#x2013;26. doi:&#xa0;10.3390/biom10081181</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10081181</ArticleId><ArticleId IdType="pmc">PMC7463562</ArticleId><ArticleId IdType="pubmed">32824107</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuret T, Lakota K, Mali P, &#x10c;u&#x10d;nik S, Praprotnik S, Tom&#x161;i&#x10d; M, et al. . Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells. PloS One. (2018) 13:e0195346. doi:&#xa0;10.1371/journal.pone.0195346</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195346</ArticleId><ArticleId IdType="pmc">PMC5884545</ArticleId><ArticleId IdType="pubmed">29617422</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kruger A, Proal A, Kell DB, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Pharmaceuticals. (2022) 15:931. doi:&#xa0;10.3390/ph15080931</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Thomson GJA, Nunes JM, Engelbrecht AM, Nell TA, de Villiers WJS, et al. . Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation. Sci Rep. (2019) 9:1&#x2013;14. doi:&#xa0;10.1038/s41598-019-39056-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39056-x</ArticleId><ArticleId IdType="pmc">PMC6395759</ArticleId><ArticleId IdType="pubmed">30816210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn HJ, Zamolodchikov D, Cortes-Canteli M, Norris EH, Glickman JF, Strickland S. Alzheimer&#x2019;s disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization. Proc Natl Acad Sci U.S.A. (2010) 107:21812&#x2013;7. doi:&#xa0;10.1073/pnas.1010373107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010373107</ArticleId><ArticleId IdType="pmc">PMC3003082</ArticleId><ArticleId IdType="pubmed">21098282</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;estan M, Marinovi&#x107; S, Kavazovi&#x107; I, Cekinovi&#x107; &#x110;, Wueest S, Turk Wensveen T, et al. . Virus-induced interferon-&#x3b3; Causes insulin resistance in skeletal muscle and derails glycemic control in obesity. Immunity. (2018) 49:164&#x2013;177.e6. doi:&#xa0;10.1016/J.IMMUNI.2018.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IMMUNI.2018.05.005</ArticleId><ArticleId IdType="pubmed">29958802</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan K, MacIver NJ. Viral infection &#x201c;Interferes&#x201d; with glucose tolerance. Immunity. (2018) 49:6&#x2013;8. doi:&#xa0;10.1016/j.immuni.2018.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.06.013</ArticleId><ArticleId IdType="pubmed">30021147</ArticleId></ArticleIdList></Reference><Reference><Citation>
ICIMH 2022 abstracts (2022). Available online at: https://doi.org/101177/2164957X221096590.</Citation></Reference><Reference><Citation>Chong ACN, Vogt MC, Hill AS, Br&#xfc;ning JC, Zeltser LM. Central insulin signaling modulates hypothalamus-pituitary-adrenal axis responsiveness. Mol Metab. (2014) 4:83&#x2013;92. doi:&#xa0;10.1016/J.MOLMET.2014.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLMET.2014.12.001</ArticleId><ArticleId IdType="pmc">PMC4314547</ArticleId><ArticleId IdType="pubmed">25685696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain K, Hindmarsh P, Aynsley-Green A. Neonates with symptomatic hyperinsulinemic hypoglycemia generate inappropriately low serum cortisol counterregulatory hormonal responses. J Clin Endocrinol Metab. (2003) 88:4342&#x2013;7. doi:&#xa0;10.1210/jc.2003-030135</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2003-030135</ArticleId><ArticleId IdType="pubmed">12970308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Soliman A, De Sanctis V, Alyafie F, Alaaraj N, Hamed N, et al. . Defective Cortisol Secretion in Response to Spontaneous Hypoglycemia but Normal Cortisol Response to ACTH stimulation in neonates with Hyperinsulinemic Hypoglycemia (HH). Acta Bio Medica&#x202f;: Atenei Parmensis. (2021) 92:2021182. doi:&#xa0;10.23750/ABM.V92I2.11396</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/ABM.V92I2.11396</ArticleId><ArticleId IdType="pmc">PMC8182578</ArticleId><ArticleId IdType="pubmed">33988135</ArticleId></ArticleIdList></Reference><Reference><Citation>Roque S, Correia-Neves M, Mesquita AR, Palha JA, Sousa N. Interleukin-10: A key cytokine in depression? Cardiovasc Psychiatry Neurol. (2009) 2009:1&#x2013;5. doi:&#xa0;10.1155/2009/187894</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2009/187894</ArticleId><ArticleId IdType="pmc">PMC2775686</ArticleId><ArticleId IdType="pubmed">19936104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y, Bando H, Iguchi G, Iida K, Nishizawa H, Kanie K, et al. . Clinical heterogeneity of acquired idiopathic isolated adrenocorticotropic hormone deficiency. Front Endocrinol (Lausanne). (2021) 12:578802. doi:&#xa0;10.3389/fendo.2021.578802</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.578802</ArticleId><ArticleId IdType="pmc">PMC7933588</ArticleId><ArticleId IdType="pubmed">33679614</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein NA, Andersen RN, Casson PR, Buster JE, Kramer RE. Mechanisms of insulin inhibition of ACTH-stimulated steroid secretion by cultured bovine adrenocortical cells. J Steroid Biochem Mol Biol. (1992) 41:11&#x2013;20. doi:&#xa0;10.1016/0960-0760(92)90219-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0960-0760(92)90219-9</ArticleId><ArticleId IdType="pubmed">1370906</ArticleId></ArticleIdList></Reference><Reference><Citation>Schernthaner-Reiter MH, Wolf P, Vila G, Luger A. The interaction of insulin and pituitary hormone syndromes. Front Endocrinol (Lausanne). (2021) 12:626427/BIBTEX. doi:&#xa0;10.3389/FENDO.2021.626427/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2021.626427/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8113952</ArticleId><ArticleId IdType="pubmed">33995272</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier AM, Anunciato AKO, Rosenstock TR, Glezer I. Gene expression control by glucocorticoid receptors during innate immune responses. Front Endocrinol (Lausanne). (2016) 7:31/BIBTEX. doi:&#xa0;10.3389/FENDO.2016.00031/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2016.00031/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC4835445</ArticleId><ArticleId IdType="pubmed">27148162</ArticleId></ArticleIdList></Reference><Reference><Citation>Glezer I, Chernomoretz A, David S, Plante MM, Rivest S. Genes involved in the balance between neuronal survival and death during inflammation. PloS One. (2007) 2:e310. doi:&#xa0;10.1371/journal.pone.0000310</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000310</ArticleId><ArticleId IdType="pmc">PMC1819560</ArticleId><ArticleId IdType="pubmed">17375196</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove R. Autoimmune diseases and reproductive aging. Clin Immunol. (2013) 149:251. doi:&#xa0;10.1016/j.clim.2013.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2013.02.010</ArticleId><ArticleId IdType="pmc">PMC3805815</ArticleId><ArticleId IdType="pubmed">23522436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennartsson AK, Arvidson E, B&#xf6;rjesson M, Jonsdottir IH. DHEA-S production capacity in relation to perceived prolonged stress. Stress. (2022) 25:105&#x2013;12. doi:&#xa0;10.1080/10253890.2021.2024803</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10253890.2021.2024803</ArticleId><ArticleId IdType="pubmed">35037820</ArticleId></ArticleIdList></Reference><Reference><Citation>Salek FS, Bigos KL, Kroboth PD. The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies. J Clin Pharmacol. (2002) 42:247&#x2013;66. doi:&#xa0;10.1177/00912700222011274</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00912700222011274</ArticleId><ArticleId IdType="pubmed">11865961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kairemo K, Hodolic M. Androgen receptor imaging in the management of hormone-dependent cancers with emphasis on prostate cancer. Int J Mol Sci. (2023) 24:8235. doi:&#xa0;10.3390/ijms24098235</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24098235</ArticleId><ArticleId IdType="pmc">PMC10179508</ArticleId><ArticleId IdType="pubmed">37175938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza VV, D&#x2019;Attilio L, Mahuad CV, Giri AA, Del Rey A, Besedovsky H, et al. . Altered cortisol/DHEA ratio in tuberculosis patients and its relationship with abnormalities in the mycobacterial-driven cytokine production by peripheral blood mononuclear cells. Scand J Immunol. (2007) 66:97&#x2013;103. doi:&#xa0;10.1111/j.1365-3083.2007.01952.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2007.01952.x</ArticleId><ArticleId IdType="pubmed">17587351</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratschke S, Von Dossow-Hanfstingl V, Dietz J, Schneider CP, Tufman A, Albertsmeier M, et al. . Dehydroepiandrosterone modulates T-cell response after major abdominal surgery. J Surg Res. (2014) 189:117&#x2013;25. doi:&#xa0;10.1016/j.jss.2014.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2014.02.002</ArticleId><ArticleId IdType="pubmed">24650456</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster JM, Kempen LJAP, Hardy RS, Langen RCJ. Inflammation and skeletal muscle wasting during cachexia. Front Physiol. (2020) 11:597675. doi:&#xa0;10.3389/fphys.2020.597675</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.597675</ArticleId><ArticleId IdType="pmc">PMC7710765</ArticleId><ArticleId IdType="pubmed">33329046</ArticleId></ArticleIdList></Reference><Reference><Citation>Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. (2016) 5:e200. doi:&#xa0;10.1038/oncsis.2016.3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oncsis.2016.3</ArticleId><ArticleId IdType="pmc">PMC5154342</ArticleId><ArticleId IdType="pubmed">26900952</ArticleId></ArticleIdList></Reference><Reference><Citation>Baazim H, Schweiger M, Moschinger M, Xu H, Scherer T, Popa A, et al. . CD8+ T cells induce cachexia during chronic viral infection. Nat Immunol. (2019) 20:701. doi:&#xa0;10.1038/s41590-019-0397-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0397-y</ArticleId><ArticleId IdType="pmc">PMC6531346</ArticleId><ArticleId IdType="pubmed">31110314</ArticleId></ArticleIdList></Reference><Reference><Citation>Layunta E, Buey B, Mesonero JE, Latorre E. Crosstalk between intestinal serotonergic system and pattern recognition receptors on the microbiota-gut-brain axis. Front Endocrinol (Lausanne). (2021) 12:748254. doi:&#xa0;10.3389/fendo.2021.748254</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.748254</ArticleId><ArticleId IdType="pmc">PMC8607755</ArticleId><ArticleId IdType="pubmed">34819919</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza C, Matheus N, Latorre E, Castro M, Mesonero JE, Alcalde AI. Toll-like receptor 3 activation affects serotonin transporter activity and expression in human enterocyte-like Caco-2 cells. Cell Physiol Biochem. (2012) 30:187&#x2013;98. doi:&#xa0;10.1159/000339057</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339057</ArticleId><ArticleId IdType="pubmed">22759966</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry N, Margolis KG. Serotonergic mechanisms regulating the GI tract: experimental evidence and therapeutic relevance. Handb Exp Pharmacol. (2017) 239:319. doi:&#xa0;10.1007/164_2016_103</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/164_2016_103</ArticleId><ArticleId IdType="pmc">PMC5526216</ArticleId><ArticleId IdType="pubmed">28035530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormsbee HS, Fondacaro JD. Action of serotonin on the gastrointestinal tract. Proc Soc Exp Biol Med. (1985) 178:333&#x2013;8. doi:&#xa0;10.3181/00379727-178-42016</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-178-42016</ArticleId><ArticleId IdType="pubmed">3919396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol. (2005) 166:409&#x2013;19. doi:&#xa0;10.1016/S0002-9440(10)62264-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)62264-X</ArticleId><ArticleId IdType="pmc">PMC1237049</ArticleId><ArticleId IdType="pubmed">15681825</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: A comprehensive review. Gastroenterol Hepatol (N Y). (2007) 3:112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3099351</ArticleId><ArticleId IdType="pubmed">21960820</ArticleId></ArticleIdList></Reference><Reference><Citation>Raithel M, Weidenhiller M, Hagel AFK, Hetterich U, Neurath MF, Konturek PC. The malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnoses. Dtsch Arztebl Int. (2013) 110:775. doi:&#xa0;10.3238/arztebl.2013.0775</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.2013.0775</ArticleId><ArticleId IdType="pmc">PMC3855820</ArticleId><ArticleId IdType="pubmed">24300825</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzer B, Kopp CW, Neumayer C, Koppensteiner R, Jozkowicz A, Poledniczek M, et al. . Toll-like receptors as pro-thrombotic drivers in viral infections: A narrative review. Cells. (2023) 12:1865. doi:&#xa0;10.3390/cells12141865</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12141865</ArticleId><ArticleId IdType="pmc">PMC10377790</ArticleId><ArticleId IdType="pubmed">37508529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebermeyer T, Cognasse F, Berthelot P, Mismetti P, Garraud O, Hamzeh-cognasse H. Platelet innate immune receptors and TLRs: A double-edged sword. Int J Mol Sci. (2021) 22:7894. doi:&#xa0;10.3390/ijms22157894</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157894</ArticleId><ArticleId IdType="pmc">PMC8347377</ArticleId><ArticleId IdType="pubmed">34360659</ArticleId></ArticleIdList></Reference><Reference><Citation>Anabel AS, Eduardo PC, Pedro Antonio HC, Carlos SM, Juana NM, Honorio TA, et al. . Human platelets express Toll-like receptor 3 and respond to poly I:C. Hum Immunol. (2014) 75:1244&#x2013;51. doi:&#xa0;10.1016/j.humimm.2014.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2014.09.013</ArticleId><ArticleId IdType="pubmed">25315747</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. . The S1 protein of SARS-CoV-2 crosses the blood&#x2013;brain barrier in mice. Nat Neurosci. (2021) 24:368. doi:&#xa0;10.1038/s41593-020-00771-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams PhD MV, Cox B, Lafuse PhD WP, Ariza ME. Epstein-barr virus dUTPase induces neuroinflammatory mediators: implications for myalgic encephalomyelitis/chronic fatigue syndrome. Clin Ther. (2019) 41:848&#x2013;63. doi:&#xa0;10.1016/j.clinthera.2019.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.04.009</ArticleId><ArticleId IdType="pmc">PMC6525645</ArticleId><ArticleId IdType="pubmed">31040055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocamonde B, Hasan U, Mathieu C, Dutartre H. Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responses. Front Neurosci. (2023) 17:1108212/BIBTEX. doi:&#xa0;10.3389/FNINS.2023.1108212/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNINS.2023.1108212/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC10017484</ArticleId><ArticleId IdType="pubmed">36937670</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R, Connolly KJ, Brekk OR, Hinrich AJ, Hastings ML, Isacson O, et al. . Viral-like TLR3 induction of cytokine networks and &#x3b1;-synuclein are reduced by complement C3 blockade in mouse brain. Sci Rep. (2023) 13:1&#x2013;14. doi:&#xa0;10.1038/s41598-023-41240-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-41240-z</ArticleId><ArticleId IdType="pmc">PMC10499893</ArticleId><ArticleId IdType="pubmed">37704739</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson G. Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition. Prog Neuropsychopharmacol Biol Psychiatry. (2018) 80:255&#x2013;66. doi:&#xa0;10.1016/j.pnpbp.2017.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2017.04.022</ArticleId><ArticleId IdType="pubmed">28433458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehraj V, Routy J-P. Tryptophan catabolism in chronic viral infections: handling uninvited guests. Int J Tryptophan Res. (2015) 8:41. doi:&#xa0;10.4137/IJTR.S26862</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/IJTR.S26862</ArticleId><ArticleId IdType="pmc">PMC4527356</ArticleId><ArticleId IdType="pubmed">26309411</ArticleId></ArticleIdList></Reference><Reference><Citation>Baev AY, Vinokurov AY, Novikova IN, Dremin VV, Potapova EV, Abramov AY. Interaction of mitochondrial calcium and ROS in neurodegeneration. Cells. (2022) 11:706. doi:&#xa0;10.3390/cells11040706</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11040706</ArticleId><ArticleId IdType="pmc">PMC8869783</ArticleId><ArticleId IdType="pubmed">35203354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavyani B, Lidbury BA, Schloeffel R, Fisher PR, Missailidis D, Annesley SJ, et al. . Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle? Cell Mol Life Sci. (2022) 79:1&#x2013;19. doi:&#xa0;10.1007/S00018-022-04380-5/FIGURES/2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00018-022-04380-5/FIGURES/2</ArticleId><ArticleId IdType="pmc">PMC9276562</ArticleId><ArticleId IdType="pubmed">35821534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares RG, Tasca CI, Santos CES, Alves LB, Porci&#xfa;ncula LO, Emanuelli T, et al. . Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int. (2002) 40:621&#x2013;7. doi:&#xa0;10.1016/S0197-0186(01)00133-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-0186(01)00133-4</ArticleId><ArticleId IdType="pubmed">11900857</ArticleId></ArticleIdList></Reference><Reference><Citation>Won SJ, Jang BG, Yoo BH, Sohn M, Lee MW, Choi BY, et al. . Prevention of acute/severe hypoglycemia-induced neuron death by lactate administration. J Cereb Blood Flow Metab. (2012) 32:1086. doi:&#xa0;10.1038/jcbfm.2012.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2012.30</ArticleId><ArticleId IdType="pmc">PMC3367225</ArticleId><ArticleId IdType="pubmed">22453629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Li J, Wang MY, Pan ZY, Li ZQ, Wang ZF. Chronic microglial inflammation promotes neuronal lactate supply but impairs its utilization in primary rat astrocyte-neuron co-cultures. Biochem Biophys Res Commun. (2022) 607:28&#x2013;35. doi:&#xa0;10.1016/j.bbrc.2022.03.122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2022.03.122</ArticleId><ArticleId IdType="pubmed">35366540</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. . Transcriptional evidence for the &#x201c;Reverse Warburg Effect&#x201d; in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer&#x2019;s disease, and &#x201c;Neuron-Glia Metabolic Coupling. Aging (Albany NY). (2010) 2:185. doi:&#xa0;10.18632/aging.v2i4</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.v2i4</ArticleId><ArticleId IdType="pmc">PMC2881509</ArticleId><ArticleId IdType="pubmed">20442453</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata MM, Kong X, Moncada E, Chen Y, Imamura H, Wang P, et al. . NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Mol Biol Cell. (2019) 30:2584&#x2013;97. doi:&#xa0;10.1091/MBC.E18-10-0650/ASSET/IMAGES/LARGE/MBC-30-2584-G008.JPEG</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/MBC.E18-10-0650/ASSET/IMAGES/LARGE/MBC-30-2584-G008.JPEG</ArticleId><ArticleId IdType="pmc">PMC6740200</ArticleId><ArticleId IdType="pubmed">31390283</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc S, Kurnaz IA, Ozilgen M. Astrocyte - neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions - in silico study supported by in vitro expression data. BMC Syst Biol. (2011) 5:1&#x2013;13. doi:&#xa0;10.1186/1752-0509-5-162/TABLES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-5-162/TABLES/1</ArticleId><ArticleId IdType="pmc">PMC3202240</ArticleId><ArticleId IdType="pubmed">21995951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanbari Movahed Z, Rastegari-Pouyani M, Mhossein M, Mansouri K. Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell? Biomedicine Pharmacotherapy. (2019) 112:108690. doi:&#xa0;10.1016/j.biopha.2019.108690</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.108690</ArticleId><ArticleId IdType="pubmed">30798124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahm F, Oezen I, Opitz CA, Radlwimmer B, Von Deimling A, Ahrendt T, et al. . The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Res. (2013) 73:3225&#x2013;34. doi:&#xa0;10.1158/0008-5472.CAN-12-3831</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-12-3831</ArticleId><ArticleId IdType="pubmed">23548271</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo-Huitr&#xf3;n R, Ugalde Mu&#xf1;iz P, Pineda B, Pedraza-Chaverr&#xed; J, R&#xed;os C, P&#xe9;rez-De La Cruz V. Quinolinic acid: An endogenous neurotoxin with multiple targets. Oxid Med Cell Longev. (2013) 2013:104024. doi:&#xa0;10.1155/2013/104024</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/104024</ArticleId><ArticleId IdType="pmc">PMC3780648</ArticleId><ArticleId IdType="pubmed">24089628</ArticleId></ArticleIdList></Reference><Reference><Citation>Salech F, Ponce DP, Paula-Lima AC, SanMartin CD, Behrens MI. Nicotinamide, a poly [ADP-ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of alzheimer&#x2019;s disease. Front Aging Neurosci. (2020) 12:255/BIBTEX. doi:&#xa0;10.3389/FNAGI.2020.00255/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNAGI.2020.00255/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC7438969</ArticleId><ArticleId IdType="pubmed">32903806</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, et al. . NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. (2020) 5:227. doi:&#xa0;10.1038/s41392-020-00311-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00311-7</ArticleId><ArticleId IdType="pmc">PMC7539288</ArticleId><ArticleId IdType="pubmed">33028824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Dai S, Yang Y, Wei J, Li X, Luo P, et al. . Role of sirtuin 3 in degenerative diseases of the central nervous system. Biomolecules. (2023) 13:735. doi:&#xa0;10.3390/biom13050735</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13050735</ArticleId><ArticleId IdType="pmc">PMC10216547</ArticleId><ArticleId IdType="pubmed">37238605</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao F, Gong Z. The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxid Med Cell Longev. (2020) 2020:6782872. doi:&#xa0;10.1155/2020/6782872</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6782872</ArticleId><ArticleId IdType="pmc">PMC7519200</ArticleId><ArticleId IdType="pubmed">33014276</ArticleId></ArticleIdList></Reference><Reference><Citation>Layunta E, Buey B, Mesonero JE, Latorre E. Crosstalk between intestinal serotonergic system and pattern recognition receptors on the microbiota&#x2013;gut&#x2013;brain axis. Front Endocrinol (Lausanne). (2021) 12:748254/XML/NLM. doi:&#xa0;10.3389/FENDO.2021.748254/XML/NLM</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2021.748254/XML/NLM</ArticleId><ArticleId IdType="pmc">PMC8607755</ArticleId><ArticleId IdType="pubmed">34819919</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda M, Ifuku M, Hossain MS, Katafuchi T. Glial activation and expression of the serotonin transporter in chronic fatigue syndrome. Front Psychiatry. (2018) 9:589. doi:&#xa0;10.3389/fpsyt.2018.00589</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00589</ArticleId><ArticleId IdType="pmc">PMC6250825</ArticleId><ArticleId IdType="pubmed">30505285</ArticleId></ArticleIdList></Reference><Reference><Citation>Katafuchi T, Kondo T, Take S, Yoshimura M. Brain cytokines and the 5-HT system during poly I:C-induced fatigue. Ann N Y Acad Sci. (2006) 1088:230&#x2013;7. doi:&#xa0;10.1196/annals.1366.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1366.020</ArticleId><ArticleId IdType="pubmed">17192569</ArticleId></ArticleIdList></Reference><Reference><Citation>Malynn S, Campos-Torres A, Moynagh P, Haase J. The pro-inflammatory cytokine TNF-&#x3b1; Regulates the activity and expression of the serotonin transporter (SERT) in astrocytes. Neurochemical Res. (2013) 38:694&#x2013;704. doi:&#xa0;10.1007/s11064-012-0967-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-012-0967-y</ArticleId><ArticleId IdType="pubmed">23338678</ArticleId></ArticleIdList></Reference><Reference><Citation>Korte-Bouws GAH, van Heesch F, Westphal KGC, Ankersmit LMJ, van Oosten EM, G&#xfc;nt&#xfc;rk&#xfc;n O, et al. . Bacterial lipopolysaccharide increases serotonin metabolism in both medial prefrontal cortex and nucleus accumbens in male wild type rats, but not in serotonin transporter knockout rats. Pharmaceuticals. (2018) 11:66. doi:&#xa0;10.3390/ph11030066</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph11030066</ArticleId><ArticleId IdType="pmc">PMC6160917</ArticleId><ArticleId IdType="pubmed">29976854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ping F, Shang J, Zhou J, Zhang H, Zhang L. 5-HT(1A) receptor and apoptosis contribute to interferon-&#x3b1;-induced &#x201c;depressive-like&#x201d; behavior in mice. Neurosci Lett. (2012) 514:173&#x2013;8. doi:&#xa0;10.1016/j.neulet.2012.02.087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.02.087</ArticleId><ArticleId IdType="pubmed">22414862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesch KP, S&#xf6;hnle K, Poten B, Schoellnhammer G, Rupprecht R, Schulte HM. Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists. J Clin Endocrinol Metab. (1990) 70:670&#x2013;4. doi:&#xa0;10.1210/jcem-70-3-670</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem-70-3-670</ArticleId><ArticleId IdType="pubmed">1968468</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama S, Nei K, Tanaka C. Regulation of glutamate release via NMDA and 5-HT1A receptors in Guinea pig dentate gyrus. Brain Res. (1996) 728:175&#x2013;80. doi:&#xa0;10.1016/0006-8993(96)00395-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(96)00395-2</ArticleId><ArticleId IdType="pubmed">8864479</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki I, Asanuma M. Serotonin 1A receptors on astrocytes as a potential target for the treatment of parkinson&#x2019;s disease. Curr Med Chem. (2016) 23:686. doi:&#xa0;10.2174/0929867323666160122115057</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867323666160122115057</ArticleId><ArticleId IdType="pmc">PMC4997990</ArticleId><ArticleId IdType="pubmed">26795196</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki I, Asanuma M. Multifunctional metallothioneins as a target for neuroprotection in parkinson&#x2019;s disease. Antioxidants. (2023) 12:894. doi:&#xa0;10.3390/antiox12040894</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12040894</ArticleId><ArticleId IdType="pmc">PMC10135286</ArticleId><ArticleId IdType="pubmed">37107269</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. (2016) 354:481. doi:&#xa0;10.1126/science.aaf6284</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6284</ArticleId><ArticleId IdType="pmc">PMC5539971</ArticleId><ArticleId IdType="pubmed">27708054</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, et al. . Exhausted cytotoxic control of epstein-barr virus in human lupus. PloS Pathog. (2011) 7:1002328. doi:&#xa0;10.1371/journal.ppat.1002328</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002328</ArticleId><ArticleId IdType="pmc">PMC3197610</ArticleId><ArticleId IdType="pubmed">22028659</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. (2010) 49:1603. doi:&#xa0;10.1016/j.freeradbiomed.2010.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.09.006</ArticleId><ArticleId IdType="pmc">PMC2990475</ArticleId><ArticleId IdType="pubmed">20840865</ArticleId></ArticleIdList></Reference><Reference><Citation>Barroso M, Handy DE, Castro R. The link between hyperhomocysteinemia and hypomethylation: Implications for cardiovascular disease. J Inborn Errors Metab Screen. (2017) 5:e160024. doi:&#xa0;10.1177/2326409817698994/ASSET/IMAGES/LARGE/10.1177_2326409817698994-FIG4.JPEG</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2326409817698994/ASSET/IMAGES/LARGE/10.1177_2326409817698994-FIG4.JPEG</ArticleId></ArticleIdList></Reference><Reference><Citation>Kgatle MM, Spearman CW, Kalla AA, Hairwadzi HN. DNA oncogenic virus-induced oxidative stress, genomic damage, and aberrant epigenetic alterations. Oxid Med Cell Longev. (2017) 2017:3179421. doi:&#xa0;10.1155/2017/3179421</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/3179421</ArticleId><ArticleId IdType="pmc">PMC5504953</ArticleId><ArticleId IdType="pubmed">28740569</ArticleId></ArticleIdList></Reference><Reference><Citation>Jill James S, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr. (2002) 132:2361S&#x2013;6S. doi:&#xa0;10.1093/jn/132.8.2361S</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/132.8.2361S</ArticleId><ArticleId IdType="pubmed">12163693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmierczak-Bar&#xe1; Nska K, Karwowski J;, Karm&#xe1; BT;, Halczuk K, Ka&#xb4;zmierczakka&#xb4;zmierczak-Bar&#xe1; Nska J, Karwowski BT, et al. . Vitamin B12&#x2014;Multifaceted in vivo functions and in vitro applications. Nutrients. (2023) 15:2734. doi:&#xa0;10.3390/NU15122734</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/NU15122734</ArticleId><ArticleId IdType="pmc">PMC10305463</ArticleId><ArticleId IdType="pubmed">37375638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupey-Green LN, Moquin SA, Martin KA, McDevitt SM, Hulse M, Caruso LB, et al. . PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter. Virology. (2017) 507:220. doi:&#xa0;10.1016/j.virol.2017.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2017.04.006</ArticleId><ArticleId IdType="pmc">PMC5521201</ArticleId><ArticleId IdType="pubmed">28456021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupey-Green LN, Caruso LB, Madzo J, Martin KA, Tan Y, Hulse M, et al. . PARP1 stabilizes CTCF binding and chromatin structure to maintain epstein-barr virus latency type. J Virol. (2018) 92:755&#x2013;73. doi:&#xa0;10.1128/JVI.00755-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00755-18</ArticleId><ArticleId IdType="pmc">PMC6146685</ArticleId><ArticleId IdType="pubmed">29976663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezeshki PS, Rezaei N. Immune checkpoint inhibition in COVID-19: risks and benefits. Expert Opin Biol Ther. (2021) 21:1. doi:&#xa0;10.1080/14712598.2021.1887131</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2021.1887131</ArticleId><ArticleId IdType="pmc">PMC7898453</ArticleId><ArticleId IdType="pubmed">33543652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusa A, Alvarez C, Saxena Beem S, Schwartz TA, Ishizawar R. Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy. BMC Rheumatol. (2022) 6:1&#x2013;12. doi:&#xa0;10.1186/S41927-022-00297-5/FIGURES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S41927-022-00297-5/FIGURES/3</ArticleId><ArticleId IdType="pmc">PMC9641936</ArticleId><ArticleId IdType="pubmed">36345032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceschi A, Noseda R, Palin K, Verhamme K. Immune checkpoint inhibitor-related cytokine release syndrome: analysis of WHO global pharmacovigilance database. Front Pharmacol. (2020) 11:557. doi:&#xa0;10.3389/fphar.2020.00557</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00557</ArticleId><ArticleId IdType="pmc">PMC7212758</ArticleId><ArticleId IdType="pubmed">32425791</ArticleId></ArticleIdList></Reference><Reference><Citation>CecChinato V, Tryniszewska E, Ma ZM, Vaccari M, Boasso A, Tsai W-P, et al. . Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J Immunol. (2008) 180:5439. doi:&#xa0;10.4049/jimmunol.180.8.5439</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.8.5439</ArticleId><ArticleId IdType="pmc">PMC2768121</ArticleId><ArticleId IdType="pubmed">18390726</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin R, Zhao C, Wang CJ, Xu W, Zhao JY, Lin Y, et al. . Tryptophan potentiates CD8+ T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation. J Immunother Cancer. (2021) 9:e002840. doi:&#xa0;10.1136/jitc-2021-002840</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2021-002840</ArticleId><ArticleId IdType="pmc">PMC8323461</ArticleId><ArticleId IdType="pubmed">34326168</ArticleId></ArticleIdList></Reference><Reference><Citation>Terness P, Bauer TM, R&#xf6;se L, Dufter C, Watzlik A, Simon H, et al. . Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase&#x2013;expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med. (2002) 196:447. doi:&#xa0;10.1084/jem.20020052</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20020052</ArticleId><ArticleId IdType="pmc">PMC2196057</ArticleId><ArticleId IdType="pubmed">12186837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee GK, Park HJ, MacLeod M, Chandler P, Munn DH, Mellor AL. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology. (2002) 107:452. doi:&#xa0;10.1046/j.1365-2567.2002.01526.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.2002.01526.x</ArticleId><ArticleId IdType="pmc">PMC1782830</ArticleId><ArticleId IdType="pubmed">12460190</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL. Understanding the benign nature of SIV infection in natural hosts. J Clin Invest. (2007) 117:3148. doi:&#xa0;10.1172/JCI33034</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI33034</ArticleId><ArticleId IdType="pmc">PMC2045617</ArticleId><ArticleId IdType="pubmed">17975656</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambichler T, Reuther J, Scheel CH, Becker JC. On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19. J Immunother Cancer. (2020) 8:1145. doi:&#xa0;10.1136/jitc-2020-001145</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-001145</ArticleId><ArticleId IdType="pmc">PMC7358098</ArticleId><ArticleId IdType="pubmed">32611687</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafayev K, Torres H. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Clin Microbiol Infection. (2022) 28:1321&#x2013;7. doi:&#xa0;10.1016/j.cmi.2022.02.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.042</ArticleId><ArticleId IdType="pubmed">35283317</ArticleId></ArticleIdList></Reference><Reference><Citation>Mal&#xed;kov&#xe1; H, Hole&#x161;ta M, Fialova A, Arenbergerova M, Weichet J. Hypophysitis&#xa0;and other autoimmune complications related to immune checkpoints inhibitors&#xb4; treatment: Spectrum of imaging appearances. Neuro Endocrinol Lett. (2018) 39:196&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">30431741</ArticleId></ArticleIdList></Reference><Reference><Citation>Noto H, Tsukamoto K, Hayashi S, Takano K, Fujita T, Kimura S. Spontaneous recovery from hypopituitarism in a man with lymphocytic hypophysitis A case report. Endocr J. (2001) 48:483&#x2013;6. doi:&#xa0;10.1507/endocrj.48.483</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.48.483</ArticleId><ArticleId IdType="pubmed">11603571</ArticleId></ArticleIdList></Reference><Reference><Citation>Benabderrahim K. Autoimmune hypophysitis and viral infection in a pregnant woman: a challengeable case. Pan Afr Med J. (2020) 36:1&#x2013;5. doi:&#xa0;10.11604/pamj.2020.36.28.22454</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2020.36.28.22454</ArticleId><ArticleId IdType="pmc">PMC7388598</ArticleId><ArticleId IdType="pubmed">32774605</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Ruiz-Ruig&#xf3;mez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, Gonz&#xe1;lez-Cuadrado C, et al. . A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomedicines. (2021) 9:1540. doi:&#xa0;10.3390/BIOMEDICINES9111540/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES9111540/S1</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR. Autoimmune hypophysitis. Endocr Rev. (2005) 26:599&#x2013;614. doi:&#xa0;10.1210/er.2004-0011</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2004-0011</ArticleId><ArticleId IdType="pubmed">15634713</ArticleId></ArticleIdList></Reference><Reference><Citation>
Somasundaram NP, Gunatilake SSC. Infections in endocrinology: viruses, in: Endotext (2021). Available online at: https://www.ncbi.nlm.nih.gov/books/NBK568565/ (Accessed March 21, 2024).</Citation></Reference><Reference><Citation>Amylidi AL, Gogadis A, Yerolatsite M, Zarkavelis G, Torounidou N, Keramisanou V, et al. . Exploring a rarity: incidence of and therapeutic approaches for neurological complications and hypophysitis in cancer patients on immune checkpoint inhibitors&#x2014;A single-center study. Curr Oncol 2023 Vol 30 Pages 10509-10518. (2023) 30:10509&#x2013;18. doi:&#xa0;10.3390/curroncol30120766</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/curroncol30120766</ArticleId><ArticleId IdType="pmc">PMC10742161</ArticleId><ArticleId IdType="pubmed">38132400</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacques JP, Valadares LP, Moura AC, Oliveira MRF, Naves LA. Frequency and clinical characteristics of hypophysitis and hypopituitarism in patients undergoing immunotherapy &#x2013; A systematic review. Front Endocrinol (Lausanne). (2023) 14:1091185/BIBTEX. doi:&#xa0;10.3389/FENDO.2023.1091185/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2023.1091185/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC9974646</ArticleId><ArticleId IdType="pubmed">36875457</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno T, Takahashi R, Kamiyama T, Suzuki A, Suzuki M. Neuroleptic Malignant syndrome with adrenal insufficiency after BNT162b2 COVID-19 vaccination in a man taking valproate: A case report. Am J Case Rep. (2022) 23:0&#x2013;0. doi:&#xa0;10.12659/AJCR.936217</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.936217</ArticleId><ArticleId IdType="pmc">PMC9087139</ArticleId><ArticleId IdType="pubmed">35514081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chac&#xf3;n AGM, Wang C, Waqar D, Syeda SA, Kumar R, MeGhana DR. Long-term usage of oral glucocorticoids leading to adrenal insufficiency: A comprehensive review of the literature. Cureus. (2023) 15:e38948. doi:&#xa0;10.7759/cureus.38948</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.38948</ArticleId><ArticleId IdType="pmc">PMC10257969</ArticleId><ArticleId IdType="pubmed">37309331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhang Z, Liu J, Guo M, Li H. Panax Ginseng in the treatment of Alzheimer&#x2019;s disease and vascular dementia. J Ginseng Res. (2023) 47:506&#x2013;14. doi:&#xa0;10.1016/j.jgr.2023.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jgr.2023.03.001</ArticleId><ArticleId IdType="pmc">PMC10310864</ArticleId><ArticleId IdType="pubmed">37397417</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang WY, Hwang JY, Cho JY. Ginsenosides from panax ginseng as key modulators of NF-&#x3ba;B signaling are powerful anti-inflammatory and anticancer agents. Int J Mol Sci. (2023) 24:6119. doi:&#xa0;10.3390/ijms24076119</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076119</ArticleId><ArticleId IdType="pmc">PMC10093821</ArticleId><ArticleId IdType="pubmed">37047092</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Zhang Z, Liu J, Qi H, Li J, Chen J, et al. . Gut microbiota: therapeutic targets of ginseng against multiple disorders and ginsenoside transformation. Front Cell Infect Microbiol. (2022) 12:853981. doi:&#xa0;10.3389/fcimb.2022.853981</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.853981</ArticleId><ArticleId IdType="pmc">PMC9084182</ArticleId><ArticleId IdType="pubmed">35548468</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y, Li M, Weng L, Huang H, Mao Y, Yang DA, et al. . Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment. J Exp Clin Cancer Res. (2023) 42:1&#x2013;19. doi:&#xa0;10.1186/S13046-023-02888-7/FIGURES/7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13046-023-02888-7/FIGURES/7</ArticleId><ArticleId IdType="pmc">PMC10683135</ArticleId><ArticleId IdType="pubmed">38012650</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub RH, Sch&#xf6;lmerich J, Zietz B. Replacement therapy with DHEA plus corticosteroids in patients with chronic inflamatory diseases - Substitutes of adrenal and sex hormones. Z Rheumatol. (2000) 59:II108&#x2013;18. doi:&#xa0;10.1007/S003930070004/METRICS</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S003930070004/METRICS</ArticleId><ArticleId IdType="pubmed">11155790</ArticleId></ArticleIdList></Reference><Reference><Citation>Minich DM, Brown BI. A review of dietary (Phyto)Nutrients for glutathione support. Nutrients. (2019) 11:2073. doi:&#xa0;10.3390/nu11092073</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11092073</ArticleId><ArticleId IdType="pmc">PMC6770193</ArticleId><ArticleId IdType="pubmed">31484368</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardhana SA, Hwee MA, Berisa M, Wells DK, Yost KE, King B, et al. . Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nat Immunol. (2020) 21:1022&#x2013;33. doi:&#xa0;10.1038/s41590-020-0725-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0725-2</ArticleId><ArticleId IdType="pmc">PMC7442749</ArticleId><ArticleId IdType="pubmed">32661364</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. (2013) 4:223. doi:&#xa0;10.1177/2040622313496126</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040622313496126</ArticleId><ArticleId IdType="pmc">PMC3752184</ArticleId><ArticleId IdType="pubmed">23997926</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Zhang X, Jin H, Chen L, Ji J, Zhang Z. Histamine intolerance&#x2014;A kind of pseudoallergic reaction. Biomolecules 2022 Vol 12 Page 454. (2022) 12:454. doi:&#xa0;10.3390/biom12030454</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12030454</ArticleId><ArticleId IdType="pmc">PMC8945898</ArticleId><ArticleId IdType="pubmed">35327646</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto T, Iwata S, Ohnuma K, Dang NH, Morimoto C. Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases. Clin Exp Immunol. (2009) 157:27. doi:&#xa0;10.1111/j.1365-2249.2009.03958.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2009.03958.x</ArticleId><ArticleId IdType="pmc">PMC2710589</ArticleId><ArticleId IdType="pubmed">19659767</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Windt GJW, Pearce EL. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol Rev. (2012) 249:27. doi:&#xa0;10.1111/j.1600-065X.2012.01150.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2012.01150.x</ArticleId><ArticleId IdType="pmc">PMC3645891</ArticleId><ArticleId IdType="pubmed">22889213</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamaidi I, Kim S. Sirtuins are crucial regulators of T cell metabolism and functions. Exp Mol Med 2022 54:3. (2022) 54:207&#x2013;15. doi:&#xa0;10.1038/s12276-022-00739-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00739-7</ArticleId><ArticleId IdType="pmc">PMC8979958</ArticleId><ArticleId IdType="pubmed">35296782</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Smith MR, Anmangandla A, Lin H. NAD+-consuming enzymes in immune defense against viral infection. Biochem J. (2021) 478:4071. doi:&#xa0;10.1042/BCJ20210181</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20210181</ArticleId><ArticleId IdType="pmc">PMC8718269</ArticleId><ArticleId IdType="pubmed">34871367</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuelsaad ASA. Supplementation with Astragalus polysaccharides alters Aeromonas-induced tissue-specific cellular immune response. Microb Pathog. (2014) 66:48&#x2013;56. doi:&#xa0;10.1016/j.micpath.2013.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2013.12.005</ArticleId><ArticleId IdType="pubmed">24456824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X-Y, Wang R-C, Qu Z-Y, Zhu Y-Z, Li Y-L. Advances on immunoregulation effect of astragalus polysaccharides. Front Natural Products. (2022) 1:971679. doi:&#xa0;10.3389/fntpr.2022.971679</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fntpr.2022.971679</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Sun X, Zhang Z, Zhang L, Yao G, Li F, et al. . The effect of Astragalus polysaccharide on the Epstein-Barr virus lytic cycle. Acta Virol. (2014) 58:76&#x2013;80. doi:&#xa0;10.4149/av_2014_01_76</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/av_2014_01_76</ArticleId><ArticleId IdType="pubmed">24717032</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Yin YL, Li D, Kim WS, Wu G. Amino acids and immune function. Br J Nutr. (2007) 98:237&#x2013;52. doi:&#xa0;10.1017/S000711450769936X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S000711450769936X</ArticleId><ArticleId IdType="pubmed">17403271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranisavljev M, Todorovic N, Ostojic J, Ostojic SM. Reduced tissue creatine levels in patients with long COVID-19: A cross-sectional study. J Postgrad Med. (2023) 69:162. doi:&#xa0;10.4103/jpgm.jpgm_65_23</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jpgm.jpgm_65_23</ArticleId><ArticleId IdType="pmc">PMC10394531</ArticleId><ArticleId IdType="pubmed">37171415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreider RB, Stout JR. Creatine in health and disease. Nutrients. (2021) 13:1&#x2013;28. doi:&#xa0;10.3390/nu13020447</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020447</ArticleId><ArticleId IdType="pmc">PMC7910963</ArticleId><ArticleId IdType="pubmed">33572884</ArticleId></ArticleIdList></Reference><Reference><Citation>Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: Molecular mechanisms and therapeutic potential. Front Immunol. (2017) 7:697/BIBTEX. doi:&#xa0;10.3389/FIMMU.2016.00697/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2016.00697/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC5247472</ArticleId><ArticleId IdType="pubmed">28163705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong G, Yang Y, Feng D, Wei K, Chen J, Chen J, et al. . Melatonin protects injured spinal cord neurons from apoptosis by inhibiting mitochondrial damage via the SIRT1/drp1 signaling pathway. Neuroscience. (2023) 534:54&#x2013;65. doi:&#xa0;10.1016/j.neuroscience.2023.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2023.10.010</ArticleId><ArticleId IdType="pubmed">37865165</ArticleId></ArticleIdList></Reference><Reference><Citation>Morvaridzadeh M, Sadeghi E, Agah S, Nachvak SM, Fazelian S, Moradi F, et al. . Effect of melatonin supplementation on oxidative stress parameters: A systematic review and meta-analysis. Pharmacol Res. (2020) 161:105210. doi:&#xa0;10.1016/j.phrs.2020.105210</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105210</ArticleId><ArticleId IdType="pubmed">33007423</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne). (2023) 10:1187163. doi:&#xa0;10.3389/fmed.2023.1187163</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa-Dzelzkaleja S, Krumina A, Capenko S, Nora-Krukle Z, Gravelsina S, Vilmane A, et al. . The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. (2023) 21:1&#x2013;12. doi:&#xa0;10.1186/S12967-023-03887-0/FIGURES/8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12967-023-03887-0/FIGURES/8</ArticleId><ArticleId IdType="pmc">PMC9847171</ArticleId><ArticleId IdType="pubmed">36653846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2018) 16:268. doi:&#xa0;10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamazaki K, Nishigaki T, Kuramoto N, Oh K, Konishi H. Secondary adrenal insufficiency after COVID-19 diagnosed by insulin tolerance test and corticotropin-releasing hormone test. Cureus. (2022) 14:e23021. doi:&#xa0;10.7759/cureus.23021</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.23021</ArticleId><ArticleId IdType="pmc">PMC8908067</ArticleId><ArticleId IdType="pubmed">35281581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, Honda H, Nakano Y, Yamamoto K, Tokumasu K, Sakurada Y, et al. . Hormonal trends in patients suffering from long COVID symptoms. Endocr J. (2022) 69:1173&#x2013;81. doi:&#xa0;10.1507/endocrj.EJ22-0093</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R, Gubbi S, Koch CA. COVID-19 and chronic fatigue syndrome: An endocrine perspective. J Clin Transl Endocrinol. (2022) 27:100284. doi:&#xa0;10.1016/j.jcte.2021.100284</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K, Ochi K, Otsuka F. Idiopathic combined adrenocorticotropin and growth hormone deficiency mimicking chronic fatigue syndrome. BMJ Case Rep. (2021) 14:244861. doi:&#xa0;10.1136/bcr-2021-244861</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-244861</ArticleId><ArticleId IdType="pmc">PMC8543625</ArticleId><ArticleId IdType="pubmed">34686480</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmel PB, Seligman TM. A pilot study employing Dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome. J Clin Rheumatol. (1999) 5:56&#x2013;9. doi:&#xa0;10.1097/00124743-199904000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00124743-199904000-00004</ArticleId><ArticleId IdType="pubmed">19078357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuratsune H, Yamaguti K, Sawada M, Kodate S, Machii T, Kanakura Y, et al. . Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med. (1998) 1:143&#x2013;6. doi:&#xa0;10.3892/ijmm</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm</ArticleId><ArticleId IdType="pubmed">9852212</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott LV, Salahuddin F, Cooney J, Svec F, Dinan TG. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. J Affect Disord. (1999) 54:129&#x2013;37. doi:&#xa0;10.1016/S0165-0327(98)00169-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0327(98)00169-4</ArticleId><ArticleId IdType="pubmed">10403156</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rensburg SJ, Potocnik FCV, Kiss T, Hugo F, Van Zijl P, Mansvelt E, et al. . Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. Brain Res Bull. (2001) 55:319&#x2013;25. doi:&#xa0;10.1016/S0361-9230(01)00478-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(01)00478-6</ArticleId><ArticleId IdType="pubmed">11470334</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezer S, Bal C, Kalem AK, Kayaaslan B, Eser F, Hasanoglu &#x130;, et al. . COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity. Endocrine. (2022) 78:373&#x2013;9. doi:&#xa0;10.1007/S12020-022-03140-6/FIGURES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12020-022-03140-6/FIGURES/3</ArticleId><ArticleId IdType="pmc">PMC9362412</ArticleId><ArticleId IdType="pubmed">35907083</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J, Takahashi T, Wood J, Lu P, Tabachnikova A, Gehlhausen JR, et al. . Sex differences in symptomatology and immune profiles of Long COVID. medRxiv. (2024):2024.02.29.24303568. doi:&#xa0;10.1101/2024.02.29.24303568</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.29.24303568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y, Otsuka Y, Sunada N, Tokumasu K, Nakano Y, Honda H, et al. . Detection of male hypogonadism in patients with post COVID-19 condition. J Clin Med. (2022) 11:1955. doi:&#xa0;10.3390/jcm11071955</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071955</ArticleId><ArticleId IdType="pmc">PMC8999458</ArticleId><ArticleId IdType="pubmed">35407562</ArticleId></ArticleIdList></Reference><Reference><Citation>Menichetti F. The potential role of hypothalamic phospholipid liposomes in the supportive therapy of some manifestations of post-COVID-19 condition: myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and brain fog. J Clin Med. (2023) 12:5478. doi:&#xa0;10.3390/jcm12175478</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12175478</ArticleId><ArticleId IdType="pmc">PMC10488182</ArticleId><ArticleId IdType="pubmed">37685544</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. doi:&#xa0;10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen Tervaert JW, Colaris MJ, van der Hulst RR. Silicone breast implants and autoimmune rheumatic diseases: Myth or reality. Curr Opin Rheumatol. (2017) 29:348&#x2013;54. doi:&#xa0;10.1097/BOR.0000000000000391</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000391</ArticleId><ArticleId IdType="pubmed">28379860</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y, Ryabkova VA, Scheibenbogen C, Brinth L, Martinez-Lavin M, Ikeda S, et al. . Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin Immunol. (2020) 214:108384. doi:&#xa0;10.1016/j.clim.2020.108384</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108384</ArticleId><ArticleId IdType="pubmed">32171889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. (2021) 4:100100. doi:&#xa0;10.1016/j.jtauto.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. . Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. (2023) 74:1&#x2013;8. doi:&#xa0;10.3233/WOR-220581</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and post-exertional malaise among patients with long COVID. Neurol Int 2023 Vol 15 Pages 1-11. (2022) 15:1&#x2013;11. doi:&#xa0;10.3390/neurolint15010001</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Agmon-Levin N, Zafrir Y, Kivity S, Balofsky A, Amital H, Shoenfeld Y. Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the &#x2018;autoimmune (auto-inflammatory) syndrome induced by adjuvants&#x2019; (ASIA). Immunol Res. (2014) 60:376&#x2013;83. doi:&#xa0;10.1007/S12026-014-8604-2/TABLES/2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12026-014-8604-2/TABLES/2</ArticleId><ArticleId IdType="pubmed">25427994</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Brinth L, Hendrickson JE, Martinez-Lavin M. Autonomic dysfunction and HPV immunization: an overview. Immunol Res. (2018) 66:744&#x2013;54. doi:&#xa0;10.1007/S12026-018-9036-1/TABLES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12026-018-9036-1/TABLES/1</ArticleId><ArticleId IdType="pubmed">30478703</ArticleId></ArticleIdList></Reference><Reference><Citation>Iremli BG, Sendur SN, Unluturk U. Three cases of subacute thyroiditis following SARS-coV-2 vaccine: postvaccination ASIA syndrome. J Clin Endocrinol Metab. (2021) 106:2600&#x2013;5. doi:&#xa0;10.1210/clinem/dgab373</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab373</ArticleId><ArticleId IdType="pmc">PMC8194612</ArticleId><ArticleId IdType="pubmed">34043800</ArticleId></ArticleIdList></Reference><Reference><Citation>Vera-Lastra O, Navarro AO, Domiguez MPC, Medina G, Valadez TIS, Jara LJ. Two cases of graves&#x2019; Disease following SARS-coV-2 vaccination: an autoimmune/inflammatory syndrome induced by adjuvants. https://home.liebertpub.com/thy. (2021) 31:1436&#x2013;9. doi:&#xa0;10.1089/thy.2021.0142</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2021.0142</ArticleId><ArticleId IdType="pubmed">33858208</ArticleId></ArticleIdList></Reference><Reference><Citation>Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, et al. . Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med. (2009) 206:1423. doi:&#xa0;10.1084/jem.20081720</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20081720</ArticleId><ArticleId IdType="pmc">PMC2715061</ArticleId><ArticleId IdType="pubmed">19487422</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson T. Epstein Barr virus infection and immune defense related to HLA-DR15: consequences for multiple sclerosis. Eur J Immunol. (2021) 51:56. doi:&#xa0;10.1002/eji.202049030</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202049030</ArticleId><ArticleId IdType="pmc">PMC7839707</ArticleId><ArticleId IdType="pubmed">33350470</ArticleId></ArticleIdList></Reference><Reference><Citation>Zdimerova H, Murer A, Engelmann C, Raykova A, Deng Y, Gujer C, et al. . Attenuated immune control of Epstein&#x2013;Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15. Eur J Immunol. (2021) 51:64&#x2013;75. doi:&#xa0;10.1002/eji.202048655</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048655</ArticleId><ArticleId IdType="pubmed">32949466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee B, Deng Y, Holler A, Nunez N, Azzi T, Vanoaica LD, et al. . CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection. vivo. PloS Pathog. (2019) 15:e1007748. doi:&#xa0;10.1371/journal.ppat.1007748</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007748</ArticleId><ArticleId IdType="pmc">PMC6542544</ArticleId><ArticleId IdType="pubmed">31145756</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S, Files JK, Fram T, Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J Invest Med. (2023) 71:545. doi:&#xa0;10.1177/10815589231158041</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589231158041</ArticleId><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Speiser DE, Utzschneider DT, Oberle SG, M&#xfc;nz C, Romero P, Zehn D. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Speiser, Daniel E; Utzschneider, Daniel T; Oberle, Susanne G; M&#xfc;nz, Christian; Romero, Pedro; Zehn, Dietmar (2014) T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion ? Nat Rev Immunol. (2014) 14:768&#x2013;74. doi:&#xa0;10.1038/nri3740</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3740</ArticleId><ArticleId IdType="pubmed">25257362</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jersey J, Carmignac D, LeTissier P, Barthlott T, Robinson I, Stockinger B. Factors affecting the susceptibility of the mouse pituitary gland to CD8 T-cell-mediated autoimmunity. Immunology. (2004) 111:254. doi:&#xa0;10.1111/j.1365-2567.2004.01821.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2004.01821.x</ArticleId><ArticleId IdType="pmc">PMC1782418</ArticleId><ArticleId IdType="pubmed">15009425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleare AJ, Heap E, Malhi GS, Wessely S, O&#x2019;Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial. Lancet. (1999) 353:455&#x2013;8. doi:&#xa0;10.1016/S0140-6736(98)04074-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)04074-4</ArticleId><ArticleId IdType="pubmed">9989716</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie R, O&#x2019;Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, et al. . Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial. JAMA. (1998) 280:1061&#x2013;6. doi:&#xa0;10.1001/jama.280.12.1061</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.280.12.1061</ArticleId><ArticleId IdType="pubmed">9757853</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin JB, Baldwin AL, Stenberg VI. General theory of inflammation: patient self-administration of hydrocortisone safely achieves superior control of hydrocortisone-responding disorders by matching dosage with symptom intensity. J Inflammation Res. (2019) 12:161. doi:&#xa0;10.2147/JIR.S195165</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S195165</ArticleId><ArticleId IdType="pmc">PMC6581742</ArticleId><ArticleId IdType="pubmed">31354330</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D, Larsson L, Bergquist J. Theory: treatments for prolonged ICU patients may provide new therapeutic avenues for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Front Med (Lausanne). (2021) 8:672370/BIBTEX. doi:&#xa0;10.3389/FMED.2021.672370/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2021.672370/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8137963</ArticleId><ArticleId IdType="pubmed">34026797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>